MGI ID of Gene	Gene Symbol	MGI ID of Allele 1	Allele 1 Symbol	MGI ID of Allele 2	Allele 2 Symbol	Strain	PhenoSlim term	J: (without the J:)	Qualifying Evidence Code	Traits Measured		survival: embryonic lethality
MGI:2150030	Actd1	MGI:2153871	Actd1<C57BL/6J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: motor capabilities/coordination/movement anomalies	65696	TAS	distance traveled		survival: perinatal lethality
MGI:2151936	Actre1	MGI:2153873	Actre<DBA/2J>	MGI:2153874	Actre<C57BL/6J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	71081	TAS	locomotor activity		survival: postnatal lethality
MGI:2151936	Actre1	MGI:2153873	Actre<DBA/2J>	MGI:2153874	Actre<C57BL/6J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	71081	TAS	locomotor activity		survival: premature death
MGI:2149041	Adip1	MGI:2153875	Adip1<LG/J>	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	62610	TAS	adiposity		embryogenesis: developmental patterning abnormalities
MGI:2150421	Alcp25	MGI:2153877	Alcp25<DBA/2Ibg>	MGI:2153877	Alcp25<DBA/2Ibg>	involves: C57BL/6Ibg # DBA/2Ibg	neurological/behavioral: feeding/drinking preference anomalies	56967	TAS	alcohol preference		embryogenesis: embryonic tissue dysmorphology
MGI:2150421	Alcp25	MGI:2153877	Alcp25<DBA/2Ibg>	MGI:2153878	Alcp25<C57BL/6Ibg>	involves: C57BL/6Ibg # DBA/2Ibg	neurological/behavioral: feeding/drinking preference anomalies	56967	TAS	alcohol preference		embryogenesis: extraembryonic tissue dysmorphology
MGI:2150421	Alcp25	MGI:2153878	Alcp25<C57BL/6Ibg>	MGI:2153878	Alcp25<C57BL/6Ibg>	involves: C57BL/6Ibg # DBA/2Ibg	neurological/behavioral: feeding/drinking preference anomalies	56967	TAS	alcohol preference		embryogenesis: placental dysmorphology
MGI:1330314	Alcp4	MGI:2153881	Alcp4<DBA/2J>	MGI:2153881	Alcp4<DBA/2J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	52086	TAS	alcohol preference		embryogenesis: no defect detected
MGI:1330314	Alcp4	MGI:2153880	Alcp4<C57BL/6J>	MGI:2153881	Alcp4<DBA/2J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	52086	TAS	alcohol preference		growth/weight abnormality: embryonic
MGI:1330314	Alcp4	MGI:2153880	Alcp4<C57BL/6J>	MGI:2153880	Alcp4<C57BL/6J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	52086	TAS	alcohol preference		growth/weight abnormality: postnatal
MGI:1309452	Alcw1	MGI:2153882	Alcw1<DBA/2J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	56967	TAS	alcohol withdrawal		eye: no defect detected
MGI:2151073	Amp2	MGI:2153884	Amp2<BALB/cJ>	MGI:2153884	Amp2<BALB/cJ>	involves: BALB/cJ # C57BL/6J	neurological/behavioral: sleep pattern/circadian rhythm anomalies	69972	TAS	circadian rhythm		coat: color anomalies
MGI:2152428	Ap1q	MGI:2153885	Ap1q<C57BL/6J>	MGI:2153885	Ap1q<C57BL/6J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	49707	TAS	alcohol preference		coat: hair follicle structure/orientation anomalies
MGI:2152428	Ap1q	MGI:2153885	Ap1q<C57BL/6J>	MGI:2153886	Ap1q<DBA/2J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	49707	TAS	alcohol preference		coat: no defect detected
MGI:2152428	Ap1q	MGI:2153886	Ap1q<DBA/2J>	MGI:2153886	Ap1q<DBA/2J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	49707	TAS	alcohol preference		skin: pigmentation anomalies
MGI:2148560	Axtex	?	?	?	?	involves: BALB/cJ # C57BL/6J	neurological/behavioral: fear/anxiety	69668	TAS	exploratory behavior		skin: texture/condition anomalies
MGI:2148544	Axtofa1	?	?	?	?	involves: BALB/cJ # C57BL/6J	neurological/behavioral: fear/anxiety	70479	TAS	open field activity		vibrissae: shape/orientation defects
MGI:2148555	Axtofd1	?	?	?	?	involves: BALB/cJ # C57BL/6J	neurological/behavioral: fear/anxiety	70479	TAS	open field defecation		extremities: limb dysmorphology
MGI:1344398	Batq1	MGI:2153893	Batq1<MH>	?	?	involves: C57BL/6J # MH	metabolism: no defect detected	55483	TAS	brown adipose tissue		extremities: tail dysmorphology
MGI:108576	Bgeq1	MGI:2153896	Bgeq1<SM/J>	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	32208	TAS	growth rate		extremities: no defect detected
MGI:108576	Bgeq1	MGI:2153895	Bgeq1<LG/J>	MGI:2153895	Bgeq1<LG/J>	involves: LG/J # SM/J	growth/weight abnormality: postnatal	60662	TAS	growth rate		teeth: tooth dysmorphology
MGI:108576	Bgeq1	MGI:2153895	Bgeq1<LG/J>	MGI:2153896	Bgeq1<SM/J>	involves: LG/J # SM/J	growth/weight abnormality: postnatal	60662	TAS	growth rate		teeth: no defect detected
MGI:108576	Bgeq1	MGI:2153896	Bgeq1<SM/J>	MGI:2153896	Bgeq1<SM/J>	involves: LG/J # SM/J	growth/weight abnormality: postnatal	60662	TAS	growth rate		ears: auditory defects/deafness
MGI:108575	Bglq1	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	32208	TAS	growth rate		ears: dysmorphology
MGI:1349434	Bmd1	MGI:2153899	Bmd1<CAST/Ei>	?	?	involves: C57BL/6J # CAST/Ei	skeletal: no defect detected	58152	TAS	bone density		ears: no defect detected
MGI:1891313	Bpq1	?	?	?	?	involves: A/J # C57BL/6J 	heart/cardiovascular system: no defect detected	66987	TAS	blood pressure		musculature: muscle dysmorphology
MGI:1891314	Bpq2	?	?	?	?	involves: A/J # C57BL/6J 	heart/cardiovascular system: no defect detected	66987	TAS	blood pressure		musculature: physiological defects
MGI:2137480	Bslm3	?	?	?	?	involves: BALB/cJ # LP/J	neurological/behavioral: motor capabilities/coordination/movement anomalies	68417	TAS	locomotor activity		musculature: no defect detected
MGI:1932502	Bw17	?	?	?	?	involves: A/J # SM/J	growth/weight abnormality: postnatal	64138	TAS	body weight		skeletal: osteogenesis/developmental anomalies
MGI:1316682	Bw5	?	?	?	?	involves: DU6 #DUKs 	growth/weight abnormality: postnatal	49578	TAS	body weight		skeletal: axial defects
MGI:1316682	Bw5	MGI:2153919	Bw5<DU6i>	?	?	involves: DBA/2 # DU6i	growth/weight abnormality: postnatal	66233	TAS	body weight		skeletal: extremities defects
MGI:1891193	Bwtq1	?	?	?	?	involves: C57BL/6J # DBA/2J	growth/weight abnormality: postnatal	53812	TAS	body weight		skeletal: craniofacial defects
MGI:2150827	Cafq1	?	?	?	?	involves: ANP # C3H/HeJ	metabolism: no defect detected	68139	TAS	caffeine metabolism		skeletal: no defect detected
MGI:1891174	Cbm1	?	?	?	?	involves: C57BL/6J # DBA/2J	central nervous system: other dysmorphology	70179	TAS	brain weight		neurological/behavioral: aggression
MGI:2148995	Ccrs1	?	?	?	?	involves: C57BL/6By # NZB/B1NJ	central nervous system: other dysmorphology	51052	TAS	brain size		neurological/behavioral: learning/memory impairment
MGI:2151890	Cgnz1	MGI:2153939	Cgnz1<C57L/J>	MGI:2153939	Cgnz1<C57L/J>	involves: C57L/J # NZM2328/J	immune system: hypersensitivity	71397	TAS	glomerulonephritis		neurological/behavioral: seizures/epilepsy
MGI:2151890	Cgnz1	MGI:2153936	Cgnz1<NZM2328/J>	MGI:2153939	Cgnz1<C57L/J>	involves: C57L/J # NZM2328/J	immune system: hypersensitivity	71397	TAS	glomerulonephritis		neurological/behavioral: fear/anxiety
MGI:2151890	Cgnz1	MGI:2153936	Cgnz1<NZM2328/J>	MGI:2153936	Cgnz1<NZM2328/J>	involves: C57L/J # NZM2328/J	immune system: hypersensitivity	71397	TAS	glomerulonephritis		neurological/behavioral: motor capabilities/coordination/movement anomalies
MGI:2151890	Cgnz1	MGI:2153939	Cgnz1<C57L/J>	MGI:2153939	Cgnz1<C57L/J>	involves: C57L/J # NZM2328/J	immune system: hypersensitivity	71397	TAS	proteinuria		neurological/behavioral: sensory capabilities/reflexes/nociception abnormalities
MGI:2151890	Cgnz1	MGI:2153936	Cgnz1<NZM2328/J>	MGI:2153939	Cgnz1<C57L/J>	involves: C57L/J # NZM2328/J	immune system: hypersensitivity	71397	TAS	proteinuria		neurological/behavioral: maternal behavior anomalies
MGI:2151890	Cgnz1	MGI:2153936	Cgnz1<NZM2328/J>	MGI:2153936	Cgnz1<NZM2328/J>	involves: C57L/J # NZM2328/J	immune system: hypersensitivity	71397	TAS	proteinuria		neurological/behavioral: feeding/drinking preference anomalies
MGI:2137601	Chol3	MGI:2153949	Chol3<KK>	MGI:2153949	Chol3<KK>	involves: C57BL/6J # KK-A<y>	metabolism: abnormal lipid homeostasis	54322	TAS	plasma total cholesterol level		neurological/behavioral: sleep pattern/circadian rhythm anomalies
MGI:2137601	Chol3	MGI:2153949	Chol3<KK>	MGI:2153948	Chol3<C57BL/6J>	involves: C57BL/6J # KK-A<y>	metabolism: abnormal lipid homeostasis	54322	TAS	plasma total cholesterol level		neurological/behavioral: other anomalies
MGI:2137601	Chol3	MGI:2153948	Chol3<C57BL/6J>	MGI:2153948	Chol3<C57BL/6J>	involves: C57BL/6J # KK-A<y>	metabolism: abnormal lipid homeostasis	54322	TAS	plasma total cholesterol level		neurological/behavioral: no defect detected
MGI:2137601	Chol3	MGI:2153949	Chol3<KK>	MGI:2153949	Chol3<KK>	involves: C57BL/6J # KK-A<y>	metabolism: abnormal lipid homeostasis	54322	TAS	plasma HDL cholesterol level		metabolism: abnormal lipid homeostasis
MGI:2137601	Chol3	MGI:2153949	Chol3<KK>	MGI:2153948	Chol3<C57BL/6J>	involves: C57BL/6J # KK-A<y>	metabolism: abnormal lipid homeostasis	54322	TAS	plasma HDL cholesterol level		metabolism: abnormal glucose homeostasis
MGI:2137601	Chol3	MGI:2153948	Chol3<C57BL/6J>	MGI:2153948	Chol3<C57BL/6J>	involves: C57BL/6J # KK-A<y>	metabolism: abnormal lipid homeostasis	54322	TAS	plasma HDL cholesterol level		metabolism: other metabolic defect measured by clinical chemistry
MGI:2137602	Chol4	MGI:2153951	Chol4<KK>	MGI:2153951	Chol4<KK>	involves: C57BL/6J # KK-A<y>	metabolism: abnormal lipid homeostasis	54322	TAS	plasma total cholesterol level		metabolism: other metabolic defect
MGI:2137602	Chol4	MGI:2153951	Chol4<KK>	MGI:2153950	Chol4<C57BL/6J>	involves: C57BL/6J # KK-A<y>	metabolism: abnormal lipid homeostasis	54322	TAS	plasma total cholesterol level		metabolism: no defect detected
MGI:2137602	Chol4	MGI:2153950	Chol4<C57BL/6J>	MGI:2153950	Chol4<C57BL/6J>	involves: C57BL/6J # KK-A<y>	metabolism: abnormal lipid homeostasis	54322	TAS	plasma total cholesterol level		hematology: hemaotpoetic anomalies
MGI:2137602	Chol4	MGI:2153951	Chol4<KK>	MGI:2153951	Chol4<KK>	involves: C57BL/6J # KK-A<y>	metabolism: abnormal lipid homeostasis	54322	TAS	plasma HDL cholesterol level		hematology: abnormal red blood cell count/anemia
MGI:2137602	Chol4	MGI:2153951	Chol4<KK>	MGI:2153950	Chol4<C57BL/6J>	involves: C57BL/6J # KK-A<y>	metabolism: abnormal lipid homeostasis	54322	TAS	plasma HDL cholesterol level		hematology: abnormal blood coagulation
MGI:2137602	Chol4	MGI:2153950	Chol4<C57BL/6J>	MGI:2153950	Chol4<C57BL/6J>	involves: C57BL/6J # KK-A<y>	metabolism: abnormal lipid homeostasis	54322	TAS	plasma HDL cholesterol level		hematology: no defect detected
MGI:1890622	Cia9	MGI:2153955	Cia9<NOD>	?	?	involves: B10.D1-H2<q>/SgJ # NOD.C3-H2<q>/Rhd	immune system: hypersensitivity	69981	TAS	arthritis susceptibility		heart/cardiovascular system: dysmorphology
MGI:2150984	Cocrb1	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	68421	TAS	repeated movements		heart/cardiovascular system: blood circulatory defects
MGI:2150985	Cocrb2	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	68421	TAS	exploratory behavior		heart/cardiovascular system: blood pressure anomalies
MGI:2151919	Cpfd1	?	?	?	?	involves: C57BL/6By # NZB/B1NJ	central nervous system: other dysmorphology	71085	TAS	brain morphology		heart/cardiovascular system: other functional anomalies
MGI:2151920	Cpfd2	?	?	?	?	involves: C57BL/6By # NZB/B1NJ	central nervous system: other dysmorphology	71085	TAS	brain morphology		heart/cardiovascular system: no defect detected
MGI:1277142	Cplaq3	?	?	?	?	involves: BALB/cBy # C57BL/6By	neurological/behavioral: sleep pattern/circadian rhythm anomalies	36675	TAS	period of locomotor activity		respiratory system: dysmorphology
MGI:1277130	Cplaq4	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: sleep pattern/circadian rhythm anomalies	29803	TAS	period of locomotor activity		respiratory system: respiratory distress or failure/functional anomalies
MGI:2150986	Dautb1	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	68421	TAS	dopamine uptake transporter binding		respiratory system: no defect detected
MGI:2149843	Dbsty1	MGI:2154035	Dbsty1<NZO/HlLt>	MGI:2154035	Dbsty1<NZO/HlLt>	involves: NON/Lt # NZO/HlLt	growth/weight abnormality: postnatal	65256	TAS	body weight		kidney/renal system: dysmorphology
MGI:2149843	Dbsty1	MGI:2154035	Dbsty1<NZO/HlLt>	MGI:2154038	Dbsty1<NON/Lt>	involves: NON/Lt # NZO/HlLt	growth/weight abnormality: postnatal	65256	TAS	body weight		kidney/renal system: functional anomalies
MGI:2149843	Dbsty1	MGI:2154038	Dbsty1<NON/Lt>	MGI:2154038	Dbsty1<NON/Lt>	involves: NON/Lt # NZO/HlLt	growth/weight abnormality: postnatal	65256	TAS	body weight		kidney/renal system: no defect detected
MGI:2149843	Dbsty1	MGI:2154035	Dbsty1<NZO/HlLt>	MGI:2154035	Dbsty1<NZO/HlLt>	involves: NON/Lt # NZO/HlLt	metabolism: abnormal glucose homeostasis	65256	TAS	hyperinsulinemia		liver/hepatic system: dysmorphology
MGI:2149843	Dbsty1	MGI:2154035	Dbsty1<NZO/HlLt>	MGI:2154038	Dbsty1<NON/Lt>	involves: NON/Lt # NZO/HlLt	metabolism: abnormal glucose homeostasis	65256	TAS	hyperinsulinemia		liver/hepatic system: functional anomalies
MGI:2149843	Dbsty1	MGI:2154038	Dbsty1<NON/Lt>	MGI:2154038	Dbsty1<NON/Lt>	involves: NON/Lt # NZO/HlLt	metabolism: abnormal glucose homeostasis	65256	TAS	hyperinsulinemia		liver/hepatic system: no defect detected
MGI:2149843	Dbsty1	MGI:2154035	Dbsty1<NZO/HlLt>	MGI:2154035	Dbsty1<NZO/HlLt>	involves: NON/Lt # NZO/HlLt	metabolism: abnormal glucose homeostasis	65256	TAS	plasma glucose		digestive system: dysmorphology
MGI:2149843	Dbsty1	MGI:2154035	Dbsty1<NZO/HlLt>	MGI:2154038	Dbsty1<NON/Lt>	involves: NON/Lt # NZO/HlLt	metabolism: abnormal glucose homeostasis	65256	TAS	plasma glucose		digestive system: functional anomalies
MGI:2149843	Dbsty1	MGI:2154038	Dbsty1<NON/Lt>	MGI:2154038	Dbsty1<NON/Lt>	involves: NON/Lt # NZO/HlLt	metabolism: abnormal glucose homeostasis	65256	TAS	plasma glucose		digestive system: no defect detected
MGI:1350920	Emo1	MGI:2154050	Emo1<C57BL/6>	MGI:2154050	Emo1<C57BL/6>	involves: BALB/cJ # C57BL/6J	neurological/behavioral: fear/anxiety	58187	TAS	open field defecation		immune system: lymphoid development/ B lymphocyte defects
MGI:1350920	Emo1	MGI:2154048	Emo1<BALB/cJ>	MGI:2154048	Emo1<BALB/cJ>	involves: BALB/cJ # C57BL/6J	neurological/behavioral: fear/anxiety	58187	TAS	open field defecation		immune system: lymphoid development/ T lymphocyte defects
MGI:1350920	Emo1	MGI:2154050	Emo1<C57BL/6>	MGI:2154050	Emo1<C57BL/6>	involves: BALB/cJ # C57BL/6J	neurological/behavioral: fear/anxiety	58187	TAS	open field activity		immune system: other dysmorphology
MGI:1350920	Emo1	MGI:2154048	Emo1<BALB/cJ>	MGI:2154048	Emo1<BALB/cJ>	involves: BALB/cJ # C57BL/6J	neurological/behavioral: fear/anxiety	58187	TAS	open field activity		immune system: immunodeficiency
MGI:1334558	Emo3	?	?	?	?	involves: A/J # AKR/J # BALB/cJ # C3H/HeJ # C57BL/6J # DBA/2J # I/LnJ # RIIIS/J	neurological/behavioral: fear/anxiety	53482	TAS	open field defecation		immune system: hypersensitivity
MGI:1334558	Emo3	?	?	?	?	involves: A/J # AKR/J # BALB/cJ # C3H/HeJ # C57BL/6J # DBA/2J # I/LnJ # RIIIS/J	neurological/behavioral: fear/anxiety	53482	TAS	open field activity		immune system: other functional anomaly
MGI:2137481	Etlm1	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	68417	TAS	locomotor activity		immune system: no defect detected
MGI:2148643	Etohcta1	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: conditioning defect	50271	TAS	conditioned taste aversion		central nervous system: neural tube defects
MGI:1314874	Exq2	?	?	?	?	involves: A/J # C57BL/6J 	neurological/behavioral: fear/anxiety	44650	TAS	open field activity		central nervous system: other dysmorphology
MGI:1314869	Exq3	?	?	?	?	involves: A/J # C57BL/6J 	neurological/behavioral: fear/anxiety	44650	TAS	open field activity		central nervous system: LTP anomalies
MGI:1344342	Fatq1	MGI:2154089	Fatq1<MH>	?	?	involves: C57BL/6J # MH	growth/weight abnormality: postnatal	55483	TAS	adiposity		central nervous system: other functional anomalies
MGI:1346066	Gvhd1	MGI:2154093	Gvhd1<C57BL/10J>	MGI:2154093	Gvhd1<C57BL/10J>	involves: B10.D2-H2<d> # C57BL/10J	immune system: hypersensitivity	52834	TAS	splenomegaly		central nervous system: no defect detected
MGI:106010	Hcs7	MGI:2154096	Hcs7<C3H/HeJ>	?	?	involves: C3H/HeJ # C57BL/6J	tumors: increased incidence	31507	TAS	liver tumor susceptibility		peripheral nervous system: functional anomalies
MGI:106010	Hcs7	?	?	?	?	involves: C3H/HeJ # C57BL/6J	tumors: increased incidence	18565	TAS	liver tumor susceptibility		peripheral nervous system: no defect detected
MGI:2151183	Hipp1	MGI:2154097	Hipp1<C57BL/6J>	?	?	involves: C57BL/6J # DBA/2J	central nervous system: other dysmorphology	69621	TAS	brain weight		reproductive system: dysmorphology
MGI:2151183	Hipp1	MGI:2154097	Hipp1<C57BL/6J>	?	?	involves: C57BL/6J # DBA/2J	central nervous system: other dysmorphology	69621	TAS	brain weight		reproductive system: fertility/fecundity anomalies
MGI:1344355	Hlq1	MGI:2154099	Hlq1<MH>	?	?	involves: C57BL/6J # MH	metabolism: no defect detected	55483	TAS	heat loss		reproductive system: no defect detected
MGI:1344355	Hlq1	MGI:2154099	Hlq1<MH>	?	?	involves: MH # ML	metabolism: no defect detected	55483	TAS	heat loss		endocrine glands: dysmorphology
MGI:2137474	Hpic2	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: seizures/epilepsy	68417	TAS	catalepsy		endocrine glands: functional anomalies
MGI:2137474	Hpic2	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: seizures/epilepsy	61419	TAS	catalepsy		endocrine glands: no defect detected
MGI:1344386	Hrtq1	MGI:2154106	Hrtq1<MH>	?	?	involves: C57BL/6J # MH	heart/cardiovascular system: dysmorphology	55483	TAS	heart weight		tumors: increased incidence
MGI:1932506	Insq2	MGI:2154156	Insq2<SM/J>	?	?	involves: A/J # SM/J	metabolism: abnormal glucose homeostasis	64138	TAS	insulin level		tumors: no increased incidence
MGI:2148493	Insq6	MGI:2154163	Insq6<C57BL/6>	?	?	involves: 129SvIR # C57BL/6	metabolism: abnormal glucose homeostasis	61489	TAS	insulin level		other aberrant phenotype
MGI:1891848	Ity2	?	?	?	?	involves: C57BL/6J # MOLF/Ei	immune system: no defect detected	45962	TAS	resistance to infection		no obvious phenotype: no defect detected
MGI:1278337	Laq1	?	?	?	?	involves: C57BL/6-Tnfrsf6<lpr> # MRL-Tnfrsf6<lpr>	immune system: hypersensitivity	45708	TAS	arthritis		
MGI:105971	Lbw7	?	?	?	?	involves: NZB # NZW	immune system: hypersensitivity	20991	TAS	lupus
MGI:1096557	Lore1	?	?	?	?	involve: LS # SS	neurological/behavioral: no defect detected	40119	TAS	sleep time
MGI:1096557	Lore1	?	?	?	?	involve: LS # SS	neurological/behavioral: no defect detected	52088	TAS	sleep time
MGI:1096557	Lore1	?	?	?	?	involve: LS # SS	neurological/behavioral: no defect detected	38534	TAS	sleep time
MGI:2150637	Lore8	MGI:2154184	Lore8<C57BL/6IBG>			involves: C57BL/6Ibg # DBA/2Ibg	neurological/behavioral: no defect detected	66631	TAS	sleep time
MGI:2148262	Lrncs1	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: learning/memory impairment	40226	TAS	conditioned fear response
MGI:2148262	Lrncs1	MGI:2154212	Lrncs1<DBA/2J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: learning/memory impairment	43837	TAS	conditioned fear response
MGI:2148263	Lrncs2	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: learning/memory impairment	40226	TAS	conditioned fear response
MGI:2148264	Lrncs3	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: learning/memory impairment	40226	TAS	conditioned fear response
MGI:2148261	Lrnx1	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: learning/memory impairment	40226	TAS	contextual fear response
MGI:2149001	Lrnx11	?	?	?	?	involves: C3H/HeJ # C57BL/6J	neurological/behavioral: learning/memory impairment	43836	TAS	contextual fear response
MGI:2149002	Lrnx12	?	?	?	?	involves: C3H/HeJ # C57BL/6J	neurological/behavioral: learning/memory impairment	43836	TAS	contextual fear response
MGI:2148807	Manh1	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	67526	TAS	mandible morphology
MGI:2148808	Manh2	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	67526	TAS	mandible morphology
MGI:1890553	Melm1	MGI:2154228	Melm1<C57BL/6J>	MGI:2154228	Melm1<C57BL/6J>	involves: BALB/cJ # C57BL/6J	tumors: increased incidence	66211	TAS	melanoma early onset
MGI:1890553	Melm1	MGI:2154229	Melm1<BALB/cJ>	MGI:2154228	Melm1<C57BL/6J>	involves: BALB/cJ # C57BL/6J	tumors: no increased incidence	66211	TAS	melanoma early onset
MGI:1890554	Melm2	MGI:2154231	Melm2<BALB/cJ>	MGI:2154231	Melm2<BALB/cJ>	involves: BALB/cJ # C57BL/6J	tumors: no increased incidence	66211	TAS	melanoma early onset
MGI:1890554	Melm2	MGI:2154231	Melm2<BALB/cJ>	MGI:2154230	Melm2<C57BL/6J>	involves: BALB/cJ # C57BL/6J	tumors: no increased incidence	66211	TAS	melanoma early onset
MGI:1890554	Melm2	MGI:2154230	Melm2<C57BL/6J>	MGI:2154230	Melm2<C57BL/6J>	involves: BALB/cJ # C57BL/6J	tumors: increased incidence	66211	TAS	melanoma early onset
MGI:1858512	Mnek1a	MGI:2154232	Mnek1a<CAST/Ei>	?	?	involves: C57BL/6J-Nek1<kat-2J>/+ # CAST/Ei	kidney/renal system: dysmorphology	55632	TAS	kidney weight
MGI:1858512	Mnek1a	MGI:2154232	Mnek1a<CAST/Ei>	?	?	involves: C57BL/6J-Nek1<kat-2J>/+ # CAST/Ei	kidney/renal system: functional anomalies	55632	TAS	hematocrit
MGI:1353476	Mol2	?	?	?	?	involves: A/J # C57BL/6J 	immune system: other functional anomaly	58921	TAS	LPS response
MGI:1353476	Mol2	?	?	?	?	involves: BALB/cAnFCR # DBA/2N	immune system: other functional anomaly	58921	TAS	LPS response
MGI:99509	Mop3	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	17972	TAS	morphine preference
MGI:2151858	Morph1	MGI:2154243	Morph1<DBA/2J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	70377	TAS	morphine antinociception
MGI:2151858	Morph1	MGI:2154243	Morph1<DBA/2J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	70377	TAS	morphine antinociception
MGI:2149822	Mors1	MGI:2154246	Mors1<C57BL/6J>	?	?	involves: BALB/cJ # C57BL/6J-Lep<ob>/Lep<ob>	reproductive system: fertility/fecundity anomalies	52903	TAS	sterility
MGI:1891281	Nidd6	MGI:2154247	Nidd6<TSOD>	MGI:2154247	Nidd6<TSOD>	involves: BALB/cA # TSOD	growth/weight abnormality: postnatal	55285	TAS	body weight
MGI:1891281	Nidd6	MGI:2154247	Nidd6<TSOD>	MGI:2154248	Nidd6<BALB/cA>	involves: BALB/cA # TSOD	growth/weight abnormality: postnatal	55285	TAS	body weight
MGI:1891281	Nidd6	MGI:2154248	Nidd6<BALB/cA>	MGI:2154248	Nidd6<BALB/cA>	involves: BALB/cA # TSOD	growth/weight abnormality: postnatal	55285	TAS	body weight
MGI:109231	Obq2	MGI:2154249	Obq2<EL/Suz>	MGI:2154249	Obq2<EL/Suz>	involves: 129T2/SvEmsJ # EL/Suz	growth/weight abnormality: postnatal	33858	TAS	adiposity
MGI:109231	Obq2	MGI:2154249	Obq2<EL/Suz>	MGI:2154250	Obq2<129T2/SvEmsJ>	involves: 129T2/SvEmsJ # EL/Suz	growth/weight abnormality: postnatal	33858	TAS	adiposity
MGI:109231	Obq2	MGI:2154250	Obq2<129T2/SvEmsJ>	MGI:2154250	Obq2<129T2/SvEmsJ>	involves: 129T2/SvEmsJ # EL/Suz	growth/weight abnormality: postnatal	33858	TAS	adiposity
MGI:2150696	Obq7	MGI:2154252	Obq7<NZO/HlLt>	?	?	involves: NZO/HILt # SM/J	growth/weight abnormality: postnatal	67838	TAS	adiposity
MGI:2150697	Obq8	MGI:2154255	Obq8<NZO/HlLt>	?	?	involves: NZO/HILt # SM/J	growth/weight abnormality: postnatal	67838	TAS	adiposity
MGI:2150698	Obq9	MGI:2154257	Obq9<NZO/HlLt>	?	?	involves: NZO/HILt # SM/J	growth/weight abnormality: postnatal	67838	TAS	adiposity
MGI:108003	Orch4	MGI:2154295	Orch4<DBA/2J>	?	?	involves: BALB/cByJ # DBA/2	immune system: hypersensitivity	35331	TAS	orchitis
MGI:108002	Orch5	MGI:2154299	Orch5<DBA/2J>	?	?	involves: BALB/cByJ # DBA/2	immune system: hypersensitivity	35331	TAS	orchitis
MGI:1345291	Pas8	?	?	?	?	involves: A/JO1aHsd # BALB/cOlaHsd	tumors: increased incidence	50533	TAS	lung tumor susceptibility
MGI:1345291	Pas8	?	?	?	?	involves: A/JO1aHsd # BALB/cOlaHsd	tumors: increased incidence	50533	TAS	lung tumor susceptibility
MGI:1345291	Pas8	?	?	?	?	involves: A/JO1aHsd # BALB/cOlaHsd	tumors: increased incidence	50533	TAS	lung tumor susceptibility
MGI:1345638	Pbw1	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	54502	TAS	pentobarbital withdrawal
MGI:1345638	Pbw1	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	54502	TAS	pentobarbital withdrawal
MGI:1345638	Pbw1	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	54502	TAS	pentobarbital withdrawal
MGI:1345638	Pbw1	MGI:2154307	Pbw1<DBA/2J>	MGI:2154307	Pbw1<DBA/2J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	54502	TAS	pentobarbital withdrawal
MGI:1345638	Pbw1	MGI:2154307	Pbw1<DBA/2J>	MGI:2154308	Pbw1<C57BL/6J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	54502	TAS	pentobarbital withdrawal
MGI:1345638	Pbw1	MGI:2154308	Pbw1<C57BL/6J>	MGI:2154308	Pbw1<C57BL/6J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	54502	TAS	pentobarbital withdrawal
MGI:2151854	Pbwm	MGI:2154311	Pbwm<DBA/2J>	MGI:2154311	Pbwm<DBA/2J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	71080	TAS	pentobarbital withdrawal
MGI:2151209	Pgia1	MGI:2154313	Pgia1<BALB/cCrl>	MGI:2154314	Pgia1<DBA/2Crl>	involves: BALB/cCrl # DBA/2Crl	immune system: hypersensitivity	66460	TAS	autoantibody production
MGI:105970	Sbw1	?	?	?	?	involves: NZB # NZW	immune system: hypersensitivity	20991	TAS	glomerulonephritis
MGI:105970	Sbw1	?	?	?	?	involves: NZB # NZW	immune system: hypersensitivity	20991	TAS	autoantibody production
MGI:105970	Sbw1	?	?	?	?	involves: NZB # NZW	survival: premature death	20991	TAS	mortality
MGI:108569	Scc3	?	?	?	?	involves: BALB/cHeA # CcS/Dem	tumors: increased incidence	36996	TAS	colon tumor susceptibility
MGI:2149050	Skl1	MGI:2154320	Skl1<LG/J>	?	?	involves: LG/J # SM/J	skeletal: no defect detected	62610	TAS	tail length
MGI:1351472	Skts8	?	?	?	?	involves: M. spretus # NIH/Ola 	tumors: increased incidence	59049	TAS	skin tumor susceptibility
MGI:2149680	Skull1	?	?	?	?	involves: LG/J # SM/J	skeletal: no defect detected	53484	TAS	skull morphology
MGI:2149681	Skull2	?	?	?	?	involves: LG/J # SM/J	skeletal: no defect detected	53484	TAS	skull morphology
MGI:105969	Sle1	?	?	?	?	involves: C57BL/6 # NZM2410	immune system: hypersensitivity	33173	TAS	SLE
MGI:105969	Sle1	?	?	?	?	involves: C57BL/6 # NZM2410	immune system: hypersensitivity	52863	TAS	splenomegaly
MGI:105969	Sle1	?	?	?	?	involves: C57BL/6 # NZM2410	immune system: hypersensitivity	52863	TAS	anti-dsDNA antibody production
MGI:2149096	Sle10	MGI:2154333	Sle10<BXSB/J>	MGI:2154333	Sle10<BXSB/J>	involves: BXSB/J # C56BL/10Ola	immune system: hypersensitivity	60445	TAS	lymphoadenopathy
MGI:1931842	Sle1a	MGI:2154449	Sle1a<NZM2410/J>	?	?	involves: C57BL/6J # NZM2410/J	immune system: hypersensitivity	67544	TAS	anti-chromatin antibody production
MGI:1931843	Sle1b	MGI:2154451	Sle1b<NZM2410/J>	?	?	involves: C57BL/6J # NZM2410/J	immune system: hypersensitivity	67544	TAS	anti-chromatin antibody production
MGI:1931844	Sle1c	MGI:2154453	Sle1c<NZM2410/J>	?	?	involves: C57BL/6J # NZM2410/J	immune system: hypersensitivity	67544	TAS	anti-chromatin antibody production
MGI:2149093	Sle7	MGI:2154335	Sle7<BXSB/J>	MGI:2154335	Sle7<BXSB/J>	involves: BXSB/J # C56BL/10Ola	immune system: hypersensitivity	60445	TAS	glomerulonephritis
MGI:2149093	Sle7	MGI:2154335	Sle7<BXSB/J>	MGI:2154335	Sle7<BXSB/J>	involves: BXSB/J # C56BL/10Ola	immune system: hypersensitivity	60445	TAS	anti-nuclear antibody production
MGI:2149093	Sle7	MGI:2154335	Sle7<BXSB/J>	MGI:2154335	Sle7<BXSB/J>	involves: BXSB/J # C56BL/10Ola	immune system: hypersensitivity	60445	TAS	splenomegaly
MGI:2149095	Sle8	MGI:2154337	Sle8<BXSB/J>	MGI:2154337	Sle8<BXSB/J>	involves: BXSB/J # C56BL/10Ola	immune system: hypersensitivity	60445	TAS	glomerulonephritis
MGI:2149095	Sle8	MGI:2154337	Sle8<BXSB/J>	MGI:2154337	Sle8<BXSB/J>	involves: BXSB/J # C56BL/10Ola	immune system: hypersensitivity	60445	TAS	anti-nuclear antibody production
MGI:2149095	Sle8	MGI:2154337	Sle8<BXSB/J>	MGI:2154337	Sle8<BXSB/J>	involves: BXSB/J # C56BL/10Ola	immune system: hypersensitivity	60445	TAS	splenomegaly
MGI:2149094	Sle9	MGI:2154339	Sle9<BXSB/J>	MGI:2154339	Sle9<BXSB/J>	involves: BXSB/J # C56BL/10Ola	immune system: hypersensitivity	60445	TAS	anti-nuclear antibody production
MGI:2149094	Sle9	MGI:2154339	Sle9<BXSB/J>	MGI:2154339	Sle9<BXSB/J>	involves: BXSB/J # C56BL/10Ola	immune system: hypersensitivity	60445	TAS	splenomegaly
MGI:2149094	Sle9	MGI:2154339	Sle9<BXSB/J>	MGI:2154339	Sle9<BXSB/J>	involves: BXSB/J # C56BL/10Ola	immune system: hypersensitivity	60445	TAS	anti-dsDNA antibody production
MGI:2149094	Sle9	MGI:2154339	Sle9<BXSB/J>	MGI:2154339	Sle9<BXSB/J>	involves: BXSB/J # C56BL/10Ola	immune system: hypersensitivity	60445	TAS	anti-ssDNA antibody production
MGI:1335083	Sluc5	?	?	?	?	involves: B10.O20/Dem # O20/A	tumors: increased incidence	50525	TAS	lung tumor susceptibility
MGI:1335083	Sluc5	?	?	?	?	involves: B10.O20/Dem # O20/A	tumors: increased incidence	50525	TAS	lung tumor susceptibility
MGI:1888685	Sst1	MGI:2154340	Sst1<C3HeB/FeJ>	MGI:2154340	Sst1<C3HeB/FeJ>	involves: C3HeB/FeJ # C57BL/6J	immune system: no defect detected	63410	TAS	tuberculosis susceptibility
MGI:2151739	Stia1	MGI:2154343	Stia1<NOD/LtDOI>	?	?	involves: C57BL/6J # NOD/LtDOI	immune system: hypersensitivity	70882	TAS	arthritis severity
MGI:1098770	Szs1	MGI:2154345	Szs1<DBA/2J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: seizures/epilepsy	70295	TAS	seizure susceptibility
MGI:1098770	Szs1	MGI:2154345	Szs1<DBA/2J>	MGI:2154345	Szs1<DBA/2J>	involves: B6.D2-Mtv7<a>/Ty	neurological/behavioral: seizures/epilepsy	70295	TAS	seizure susceptibility
MGI:1098770	Szs1	MGI:2154345	Szs1<DBA/2J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: seizures/epilepsy	56630	TAS	seizure susceptibility
MGI:1098770	Szs1	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: seizures/epilepsy	38888	TAS	seizure susceptibility
MGI:1345649	Szs5	MGI:2154347	Szs5<DBA/2J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: seizures/epilepsy	56630	TAS	seizure susceptibility
MGI:2150671	Tbrs1	MGI:2154348	Tbrs1<C57BL/6J>	MGI:2154348	Tbrs1<C57BL/6J>	involves: C57BL/6J # DBA/2J	immune system: other functional anomaly	67658	TAS	tuberculosis resistance
MGI:2150671	Tbrs1	MGI:2154348	Tbrs1<C57BL/6J>	MGI:2154349	Tbrs1<DBA/2J>	involves: C57BL/6J # DBA/2J	immune system: other functional anomaly	67658	TAS	tuberculosis resistance
MGI:2150671	Tbrs1	MGI:2154349	Tbrs1<DBA/2J>	MGI:2154349	Tbrs1<DBA/2J>	involves: C57BL/6J # DBA/2J	immune system: other functional anomaly	67658	TAS	tuberculosis resistance
MGI:1891472	Tir3a	?	?	?	?	either: (involves: A/JOlaHsd # C57BL/6OlaHsd) or (involves: BALB/cHsd # C57BL/6JOlaHsd)	immune system: other functional anomaly	63779	TAS	trypanosome resistance
MGI:1891473	Tir3b	?	?	?	?	either: (involves: A/JOlaHsd # C57BL/6OlaHsd) or (involves: BALB/cHsd # C57BL/6JOlaHsd)	immune system: other functional anomaly	63779	TAS	trypanosome resistance
MGI:1891474	Tir3c	?	?	?	?	either: (involves: A/JOlaHsd # C57BL/6OlaHsd) or (involves: BALB/cHsd # C57BL/6JOlaHsd)	immune system: other functional anomaly	63779	TAS	trypanosome resistance
MGI:2150122	Tlln	?	?	?	?	involves: C57BL/6J # DBA/2J	skeletal: no defect detected	53812	TAS	tail length
MGI:2151921	Tne1	?	?	?	?	involves: C57BL/6By # NZB/B1NJ	neurological/behavioral: motor capabilities/coordination/movement anomalies	71085	TAS	hindlimb coordination
MGI:1274783	Vas1	?	?	?	?	involves: B10.S/DvTe # SJL/J	immune system: hypersensitivity	47821	TAS	vasitis susceptibility
MGI:1858756	Vertcling	?	?	?	?	involves: C57BL/6By # NZB/B1NJ	neurological/behavioral: motor capabilities/coordination/movement anomalies	53794	TAS	vertical clinging
MGI:1344340	Wt10q1	MGI:2154366	Wt10Q1<MH>	?	?	involves: C57BL/6J # MH	growth/weight abnormality: postnatal	55483	TAS	body weight
MGI:1344340	Wt10q1	MGI:2154366	Wt10Q1<MH>	?	?	involves: MH # ML	growth/weight abnormality: postnatal	55483	TAS	body weight
MGI:1344329	Wt3q1	MGI:2154370	Wt3q1<MH>	?	?	involves: C57BL/6J # MH	growth/weight abnormality: postnatal	55483	TAS	body weight
MGI:1344428	Wt3q2	MGI:2154372	Wt3q2<MH>	?	?	involves: C57BL/6J # MH	growth/weight abnormality: postnatal	55483	TAS	body weight
MGI:1344348	Wt6q1	MGI:2154374	Wt6q1<MH>	?	?	involves: C57BL/6J # MH	growth/weight abnormality: postnatal	55483	TAS	body weight
MGI:1344348	Wt6q1	MGI:2154374	Wt6q1<MH>	?	?	involves: MH # ML	growth/weight abnormality: postnatal	55483	TAS	body weight
MGI:1344411	Wt6q2	MGI:2154378	Wt6q2<MH>	?	?	involves: C57BL/6J # MH	growth/weight abnormality: postnatal	55483	TAS	body weight
MGI:2148988	Yaa2	?	?	?	?	involves: BXSB/J # C57BL/10Ola	immune system: hypersensitivity	49868	TAS	nephritis
MGI:2148990	Yaa3	?	?	?	?	involves: BXSB/J # C57BL/10Ola	immune system: hypersensitivity	49868	TAS	nephritis
MGI:2148991	Yaa4	?	?	?	?	involves: BXSB/J # C57BL/10Ola	immune system: hypersensitivity	49868	TAS	anti-dsDNA antibody production
MGI:1196362	Aaiq3	?	?	?	?	involves: A/J # C57BL/6J 	reproductive system: no defect detected	44129	TAS	aromatase activity
MGI:1196364	Aaiq4	?	?	?	?	involves: A/J # C57BL/6J 	reproductive system: no defect detected	44129	TAS	aromatase activity
MGI:1888528	Abhr1	?	?	?	?	involves: A/J # C3H/HeJ	immune system: hypersensitivity	66641	TAS	airway hyperresponsiveness
MGI:1888529	Abhr2	?	?	?	?	involves: A/J # C3H/HeJ	immune system: hypersensitivity	66641	TAS	airway hyperresponsiveness
MGI:2151937	Actre2	MGI:2154487	Actre2<C57BL/6J>	MGI:2154487	Actre2<C57BL/6J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	71081	TAS	locomotor activity
MGI:2151937	Actre2	MGI:2154487	Actre2<C57BL/6J>	MGI:2154488	Actre2<DBA/2J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	71081	TAS	locomotor activity
MGI:2151937	Actre2	MGI:2154488	Actre2<DBA/2J>	MGI:2154488	Actre2<DBA/2J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	71081	TAS	locomotor activity
MGI:2151937	Actre2	MGI:2154487	Actre2<C57BL/6J>	MGI:2154487	Actre2<C57BL/6J>	involves:  A/J # AKR/J # BALB/cJ # C3H/HeJ # C57BL/6J # CBA/2J # DBA/2J # LP/J	neurological/behavioral: no defect detected	71081	TAS	locomotor activity
MGI:2151937	Actre2	MGI:2154487	Actre2<C57BL/6J>	MGI:2154488	Actre2<DBA/2J>	involves:  A/J # AKR/J # BALB/cJ # C3H/HeJ # C57BL/6J # CBA/2J # DBA/2J # LP/J	neurological/behavioral: no defect detected	71081	TAS	locomotor activity
MGI:2151937	Actre2	MGI:2154488	Actre2<DBA/2J>	MGI:2154488	Actre2<DBA/2J>	involves:  A/J # AKR/J # BALB/cJ # C3H/HeJ # C57BL/6J # CBA/2J # DBA/2J # LP/J	neurological/behavioral: no defect detected	71081	TAS	locomotor activity
MGI:2151938	Actre3	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	71081	TAS	locomotor activity
MGI:2151938	Actre3	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	71081	TAS	locomotor activity
MGI:2151938	Actre3	?	?	?	?	involves:  A/J # AKR/J # BALB/cJ # C3H/HeJ # C57BL/6J # CBA/2J # DBA/2J # LP/J	neurological/behavioral: no defect detected	71081	TAS	locomotor activity
MGI:2151939	Actre4	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	71081	TAS	locomotor activity
MGI:2151939	Actre4	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	71081	TAS	locomotor activity
MGI:2151939	Actre4	?	?	?	?	involves:  A/J # AKR/J # BALB/cJ # C3H/HeJ # C57BL/6J # CBA/2J # DBA/2J # LP/J	neurological/behavioral: no defect detected	71081	TAS	locomotor activity
MGI:107468	Alcp1	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	33277	TAS	alcohol preference
MGI:107468	Alcp1	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	52086	TAS	alcohol preference
MGI:107468	Alcp1	MGI:2154973	Alcp1<DBA/2Ibg>	MGI:2154972	Alcp1<C57BL/6Ibg>	involves: C57BL/6Ibg # DBA/2Ibg	neurological/behavioral: feeding/drinking preference anomalies	56967	TAS	alcohol preference
MGI:1858454	Alcp5	?	?	?	?	involves: A/J # C57BL/6J 	neurological/behavioral: feeding/drinking preference anomalies	52467	TAS	alcohol preference
MGI:1858455	Alcp6	?	?	?	?	involves: A/J # C57BL/6J 	neurological/behavioral: feeding/drinking preference anomalies	52467	TAS	alcohol preference
MGI:2152429	Ap2q	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	49707	TAS	alcohol preference
MGI:2151119	Bdt1	?	?	?	?	involves: C57BL/6J # DBA/2J	skeletal: osteogenesis/developmental anomalies	69682	TAS	bone density
MGI:1100534	Bfq1	?	?	?	?	involves: NZB/BlNJ # SM/J	growth/weight abnormality: postnatal	42700	TAS	adiposity
MGI:1100534	Bfq1	?	?	?	?	involves: C57BL/10SnJ # LP/J	growth/weight abnormality: postnatal	42700	TAS	adiposity
MGI:108568	Bgeq2	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	32208	TAS	growth rate
MGI:108568	Bgeq2	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	60662	TAS	growth rate
MGI:108567	Bglq2	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	32208	TAS	growth rate
MGI:108567	Bglq2	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	60662	TAS	growth rate
MGI:2149372	Bglu1	MGI:2154951	Bglu1<C57BL/6Slc>	MGI:2154951	Bglu1<C57BL/6Slc>	involves: C3H/HeSlc # C57BL/6Slc	metabolism: abnormal glucose homeostasis	62933	TAS	glucose levels
MGI:2149372	Bglu1	MGI:2154951	Bglu1<C57BL/6Slc>	MGI:2154950	Bglu1<C3H/HeSlc>	involves: C3H/HeSlc # C57BL/6Slc	metabolism: abnormal glucose homeostasis	62933	TAS	glucose levels
MGI:2149372	Bglu1	MGI:2154950	Bglu1<C3H/HeSlc>	MGI:2154950	Bglu1<C3H/HeSlc>	involves: C3H/HeSlc # C57BL/6Slc	metabolism: abnormal glucose homeostasis	62933	TAS	glucose levels
MGI:104739	Bhr1	?	?	?	?	involves: A/J # C57BL/6J 	immune system: hypersensitivity	29231	TAS	airway hyperresponsiveness
MGI:2150763	Bits1	MGI:2154793	Bits1<NZB/BlNJ>	MGI:2154793	Bits1<NZB/BlNJ>	involves: C57BL/6By # NZB/BlNJ	neurological/behavioral: feeding/drinking preference anomalies	68419	TAS	bitterness sensitivity
MGI:1890966	Bts1	MGI:2155069	Bts<NON/Shi>	?	?	involves: C57BL/6JShi # NON/Shi	tumors: increased incidence	51984	TAS	bladder tumor susceptibility
MGI:1316640	Bw6	?	?	?	?	involves: DU6 #DUKs 	growth/weight abnormality: postnatal	49578	TAS	body weight
MGI:1201373	Bwfq1	?	?	?	?	involves: CAST/Ei # M16i	growth/weight abnormality: postnatal	35301	TAS	body weight
MGI:1201373	Bwfq1	?	?	?	?	involves: CAST/Ei # M16i	growth/weight abnormality: postnatal	35301	TAS	adiposity
MGI:1201415	Bwfq2	?	?	?	?	involves: CAST/Ei # M16i	growth/weight abnormality: postnatal	35301	TAS	body weight
MGI:1201415	Bwfq2	?	?	?	?	involves: CAST/Ei # M16i	growth/weight abnormality: postnatal	35301	TAS	adiposity
MGI:2137238	C10bw1	?	?	?	?	involves: C57BL/6J # M.m. castaneus	growth/weight abnormality: postnatal	64750	TAS	body weight
MGI:1933821	Cara1	MGI:2154530	Cara1<C57BL/6J>	?	?	involves: C57BL/6J-Cish2<hg>/Cish2<hg> # CAST/EiJ 	growth/weight abnormality: postnatal	68441	TAS	carcass ash weight
MGI:1933817	Carp1	MGI:2154528	Carp1<C57BL/6J>	?	?	involves: C57BL/6J-Cish2<hg>/Cish2<hg> # CAST/EiJ 	growth/weight abnormality: postnatal	68441	TAS	total carcass protein
MGI:1333775	Cia2	MGI:2154512	Cia2<C57BL/10>	?	?	involves: B10.D1-H2<q>/SgJ # NOD.C3H-H2<q>/Rhd 	immune system: hypersensitivity	69981	TAS	arthritis severity
MGI:1333775	Cia2	MGI:2154512	Cia2<C57BL/10>	?	?	involves: B10.D1-H2<q>/SgJ # NOD.C3H-H2<q>/Rhd 	immune system: hypersensitivity	69981	TAS	C5 serum levels
MGI:1333775	Cia2	MGI:2155050	Cia2<DBA/1J>	MGI:2155050	Cia2<DBA/1J>	involves: DBA/1J # SWR/J	immune system: hypersensitivity	53356	TAS	arthritis severity
MGI:1333775	Cia2	MGI:2155050	Cia2<DBA/1J>	MGI:2155049	Cia2<SWR/J>	involves: DBA/1J # SWR/J	immune system: hypersensitivity	53356	TAS	arthritis severity
MGI:1333775	Cia2	MGI:2155050	Cia2<DBA/1J>	MGI:2155050	Cia2<DBA/1J>	involves: DBA/1J # SWR/J	immune system: hypersensitivity	53356	TAS	arthritis susceptibility
MGI:1333775	Cia2	MGI:2155050	Cia2<DBA/1J>	MGI:2155049	Cia2<SWR/J>	involves: DBA/1J # SWR/J	immune system: hypersensitivity	53356	TAS	arthritis susceptibility
MGI:1333858	Cia4	?	?	?	?	involves: DBA/1J # SWR/J	immune system: hypersensitivity	53356	TAS	age of onset
MGI:2150987	Cocrb3	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	68421	TAS	exploratory behavior
MGI:2148651	Cons1	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	50271	TAS	saccharin preference
MGI:1277146	Cplaq7	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: sleep pattern/circadian rhythm anomalies	29803	TAS	period of locomotor activity
MGI:2149676	Daq17	?	?	?	?	involves: CAST/Ei # M16i	skeletal: craniofacial defects	64141	TAS	mandible morphology
MGI:2149677	Daq18	?	?	?	?	involves: CAST/Ei # M16i	skeletal: craniofacial defects	64141	TAS	mandible morphology
MGI:1928271	Diet1	MGI:2154956	Diet1<C57BL/6ByJ>	MGI:2154956	Diet1<C57BL/6ByJ>	involves: A/J # C57BL/6J 	metabolism: abnormal lipid homeostasis	61563	TAS	plasma cholesterol level
MGI:1345664	Dssc2	MGI:2155047	Dssc2<C3H/HeJ>	?	?	involves: C3H/HeJ # C57BL/6J	immune system: hypersensitivity	52852	TAS	colitis severity
MGI:1345664	Dssc2	MGI:2155047	Dssc2<C3H/HeJ>	?	?	involves: C3H/HeJ # C57BL/6J	immune system: hypersensitivity	52852	TAS	colitis susceptibility
MGI:1345664	Dssc2	MGI:2155047	Dssc2<C3H/HeJ>	?	?	involves: C3H/HeJ # C57BL/6J	immune system: hypersensitivity	52852	TAS	colon hyperplasia
MGI:1345664	Dssc2	MGI:2155047	Dssc2<C3H/HeJ>	?	?	involves: C3H/HeJ # C57BL/6J	immune system: hypersensitivity	52852	TAS	colon ulceration
MGI:1345664	Dssc2	MGI:2155047	Dssc2<C3H/HeJ>	?	?	involves: C3H/HeJ # C57BL/6J	immune system: hypersensitivity	52852	TAS	colitis % area affected
MGI:2148762	Eae21	MGI:2154824	Eae21<SJL/J>	?	?	involves: B10.S/DvTe # SJL/J	immune system: hypersensitivity	67840	TAS	mononuclear infiltration
MGI:2148762	Eae21	MGI:2154824	Eae21<SJL/J>	?	?	involves: B10.S/DvTe # SJL/J	immune system: hypersensitivity	67840	TAS	brain lesion severity
MGI:1309474	Eae8	?	?	?	?	involves: B10.S/DvTe # SJL/J	immune system: hypersensitivity	49054	TAS	EAE susceptibility
MGI:1309474	Eae8	MGI:2155128	Eae8<SJL/J>	?	?	involves: B10.S # SJL/J	immune system: hypersensitivity	34892	TAS	EAE susceptibility
MGI:95313	El2	MGI:2155257	El2<EL>	?	?	involves: ABP/LeJ # EL 	neurological/behavioral: seizures/epilepsy	11381	TAS	seizure susceptibility
MGI:2137482	Etlm2	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	68417	TAS	locomotor activity
MGI:1858387	Etohc1	MGI:2155059	Etohc1<C57BL/6J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	52468	TAS	alcohol preference
MGI:1858388	Etohc2	MGI:2155061	Etohc2<C57BL/6J>	MGI:2155061	Etohc2<C57BL/6J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	52468	TAS	alcohol preference
MGI:2148648	Etohcta2	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	50271	TAS	conditioned taste aversion
MGI:1858897	Etohila	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	52087	TAS	locomotor activity
MGI:1858902	Etohr	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	52042	TAS	locomotor activity
MGI:1329006	Fecq1	MGI:2155169	Fecq1<QSo)	MGI:2155169	Fecq1<QSo)	involves: C57BL/6J # Qso	reproductive system: fertility/fecundity anomalies	44163	TAS	litter size
MGI:1329006	Fecq1	MGI:2155169	Fecq1<QSo)	MGI:2155170	Fecq1<C57BL/6J>	involves: C57BL/6J # Qso	reproductive system: fertility/fecundity anomalies	44163	TAS	litter size
MGI:1933827	Feml1	MGI:2154532	Feml1<C57BL/6J>	?	?	involves: C57BL/6J-Cish2<hg>/Cish2<hg> # CAST/EiJ	skeletal: osteogenesis/developmental anomalies	68441	TAS	femur length
MGI:1353459	Fob1	?	?	?	?	complex	growth/weight abnormality: postnatal	59227	TAS	adiposity
MGI:1858386	Gvhd3	MGI:2154975	Gvhd3<C57BL/10>	MGI:2154975	Gvhd3<C57BL/10>	involves: B10.D2/nSnJ # DBA/2J	immune system: hypersensitivity	55766	TAS	weight loss
MGI:99636	Hcs4	MGI:2155234	Hcs4<C3H/He>	?	?	involves: C3H/He # C57BL/6JBy # M. spretus	tumors: increased incidence	20738	TAS	liver tumor susceptibility
MGI:2149551	Hdl1	?	?	?	?	involves: C57BL/6J # CAST/Ei	metabolism: abnormal lipid homeostasis	66421	TAS	plasma HDL level
MGI:1344354	Hlq2	MGI:2154977	Hlq2<MH>	?	?	involves: C57BL/6J # MH	metabolism: no defect detected	55483	TAS	heat loss
MGI:2149992	Iba1	MGI:2154942	Iba1<A/J>	?	?	involves: A/J # C57BL/6J 	metabolism: no defect detected	65478	TAS	weight loss
MGI:2148494	Insq7	?	?	?	?	involves: 129SvIR # C57BL/6	metabolism: abnormal glucose homeostasis	61489	TAS	insulin levels
MGI:1316683	Kwq1	?	?	?	?	involves: DU6 #DUKs 	kidney/renal system: dysmorphology	49578	TAS	kidney weight
MGI:1889220	Kwq6	?	?	?	?	involves: DBA/2 x DU6i	kidney/renal system: dysmorphology	66233	TAS	kidney weight
MGI:1096560	Lore2	?	?	?	?	involves: LS # SS	neurological/behavioral: no defect detected	38534	TAS	sleep time
MGI:1096560	Lore2	MGI:2155063	Lore2<LS>	MGI:2155063	Lore2<LS>	involves: LS # SS	neurological/behavioral: no defect detected	52088	TAS	sleep time
MGI:2148585	Lrnx10	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: learning/memory impairment	65698	TAS	contextual fear response
MGI:2148585	Lrnx10	MGI:2155156	Lrnx10<C57BL/6J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: learning/memory impairment	43837	TAS	contextual fear response
MGI:2148809	Manh3	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	67526	TAS	mandible morphology
MGI:2148832	Manz1	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	67526	TAS	mandible size
MGI:1858511	Mnek1b	MGI:2154980	Mnek1b<C57BL/6J>	?	?	involves: C57BL/6J-Nek1<kat-2J>/+ # CAST/Ei	kidney/renal system: functional anomalies	55632	TAS	hematocrit
MGI:1890667	Mob5	MGI:2155132	Mob5<CAST/Ei>	MGI:2155131	Mob5<C57BL/6J>	involves: CAST/Ei # C57BL/6J	growth/weight abnormality: postnatal	48038	TAS	adiposity
MGI:1890667	Mob5	?	?	?	?	involves: CAST/Ei # C57BL/6J	metabolism: abnormal glucose homeostasis	48038	TAS	insulin level
MGI:1890667	Mob5	MGI:2155132	Mob5<CAST/Ei>	MGI:2155131	Mob5<C57BL/6J>	involves: CAST/Ei # C57BL/6J	metabolism: other metabolic defect	48038	TAS	hepatic lipase activity
MGI:1890667	Mob5	?	?	?	?	involves: CAST/Ei # C57BL/6J	metabolism: abnormal lipid homeostasis	48038	TAS	plasma HDL level
MGI:1890668	Mob6	?	?	?	?	involves: CAST/Ei # C57BL/6J	metabolism: abnormal glucose homeostasis	48038	TAS	insulin level
MGI:1890668	Mob6	MGI:2155134	Mob6<CAST/Ei>	MGI:2155133	Mob6<C57BL/6J>	involves: CAST/Ei # C57BL/6J	metabolism: other metabolic defect	48038	TAS	hepatic lipase activity
MGI:1890668	Mob6	?	?	?	?	involves: CAST/Ei # C57BL/6J	metabolism: abnormal lipid homeostasis	48038	TAS	plasma HDL level
MGI:1890668	Mob6	MGI:2155134	Mob6<CAST/Ei>	MGI:2155133	Mob6<C57BL/6J>	involves: CAST/Ei # C57BL/6J	growth/weight abnormality: postnatal	48038	TAS	adiposity
MGI:1890669	Mob7	MGI:2155136	Mob7<CAST/Ei>	MGI:2155135	Mob7<C57BL/6J>	involves: CAST/Ei # C57BL/6J	growth/weight abnormality: postnatal	48038	TAS	adiposity
MGI:1890669	Mob7	?	?	?	?	involves: CAST/Ei # C57BL/6J	metabolism: abnormal lipid homeostasis	48038	TAS	plasma HDL level
MGI:1890669	Mob7	?	?	?	?	involves: CAST/Ei # C57BL/6J	metabolism: other metabolic defect measured by clinical chemistry	48038	TAS	insulin level
MGI:1346024	moth1	MGI:2154971	moth1<CAST/Ei>	MGI:2154971	moth1<CAST/Ei>	involves: C57BL/6J-tub/tub # CAST/Ei.B6-tub/tub	neurological/behavioral: sensory capabilities/reflexes/nociception abnormalities	57571	TAS	hearing ability
MGI:1346024	moth1	MGI:2154971	moth1<CAST/Ei>	MGI:2154968	moth1<C57BL/6J>	involves: C57BL/6J-tub/tub # CAST/Ei.B6-tub/tub	neurological/behavioral: sensory capabilities/reflexes/nociception abnormalities	57571	TAS	hearing ability
MGI:1346024	moth1	MGI:2154969	moth1<AKR/J>	MGI:2154969	moth1<AKR/J>	involves: AKR/J # C57BL/6J-tub/tub	neurological/behavioral: sensory capabilities/reflexes/nociception abnormalities	57571	TAS	hearing ability
MGI:1346024	moth1	MGI:2154969	moth1<AKR/J>	MGI:2154968	moth1<C57BL/6J>	involves: AKR/J # C57BL/6J-tub/tub	neurological/behavioral: sensory capabilities/reflexes/nociception abnormalities	57571	TAS	hearing ability
MGI:1891280	Nidd5	MGI:2154986	Nidd5<TSOD>	?	?	involves: BALB/cA # TSOD	metabolism: abnormal glucose homeostasis	55285	TAS	insulin level
MGI:1891280	Nidd5	MGI:2154986	Nidd5<TSOD>	?	?	involves: BALB/cA # TSOD	growth/weight abnormality: postnatal	55285	TAS	body weight
MGI:2151875	Nsv1	MGI:2154485	Nsv1<C57BL/6J>	?	?	involves: BALB/cBy # C57BL/6J 	immune system: other functional anomaly	71216	TAS	viral infection susceptibility
MGI:2151875	Nsv1	MGI:2154485	Nsv1<C57BL/6J>	?	?	involves: BALB/cBy # C57BL/6J 	immune system: other functional anomaly	71216	TAS	viral infection susceptibility
MGI:2150699	Obq10	MGI:2154915	Obq10<NZO/HlLt>	?	?	involves: NZO/HILt x SM/J 	growth/weight abnormality: postnatal	67838	TAS	adiposity
MGI:1100506	Obq3	MGI:2155173	Obq3<AKR/J>	?	?	involves: AKR/J x C57L/J	growth/weight abnormality: postnatal	39947	TAS	adiposity
MGI:1196238	Oriq2	?	?	?	?	involves: A/J x C57BL/6J 	reproductive system: no defect detected	44129	TAS	ovulation rate
MGI:109212	Sluc2	?	?	?	?	involves: B10.O20/Dem # O20/A	tumors: increased incidence	36997	TAS	lung cancer susceptibility
MGI:2151210	Pgia2	?	?	?	?	involves: BALB/cCrl # DBA/2Crl	immune system: hypersensitivity	66460	TAS	autoantibody production
MGI:2151895	Pitm1	MGI:2154482	Pitm1<C57BL/FaDk>	MGI:2154482	Pitm1<C57BL/FaDk>	involves: C57BL/FaDk # RIII/FaDk	central nervous system: other functional anomalies	70033	TAS	prion incubation time
MGI:2151895	Pitm1	MGI:2154482	Pitm1<C57BL/FaDk>	MGI:2154483	Pitm1<RIII/FaDk>	involves: C57BL/FaDk # RIII/FaDk	central nervous system: other functional anomalies	70033	TAS	prion incubation time
MGI:2151895	Pitm1	MGI:2154483	Pitm1<RIII/FaDk>	MGI:2154483	Pitm1<RIII/FaDk>	involves: C57BL/FaDk # RIII/FaDk	central nervous system: other functional anomalies	70033	TAS	prion incubation time
MGI:98238	Scc1	MGI:2155183	Scc1<STS/A>	?	?	involves: BALB/cJ # STS/A	tumors: increased incidence	44	TAS	tumor susceptibility
MGI:98238	Scc1	MGI:2155183	Scc1<STS/A>	?	?	involves: BALB/cHeA # STS/A	tumors: increased incidence	31355	TAS	tumor susceptibility
MGI:98238	Scc1	MGI:2155183	Scc1<STS/A>	?	?	involves: BALB/cHeA # STS/A	tumors: increased incidence	36996	TAS	tumor susceptibility
MGI:106228	Scc2	MGI:2155185	Scc2<STS/A>	?	?	involves: BALB/cHeA # STS/A	tumors: increased incidence	31355	TAS	tumor susceptibility
MGI:106228	Scc2	MGI:2155185	Scc2<STS/A>	?	?	involves: BALB/cHeA # STS/A	tumors: increased incidence	36996	TAS	tumor susceptibility
MGI:2149051	Skl2	MGI:2154953	Skl2<LG/J>	MGI:2154953	Skl2<LG/J>	involves: LG/J # SM/J	skeletal: no defect detected	62610	TAS	tail length
MGI:2149682	Skull3	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	53484	TAS	skull morphology
MGI:2151740	Stia2	MGI:2154506	Stia2<C57BL/6J>	MGI:2154506	Stia2<C57BL/6J>	involves: C57BL/6J # NOD/LtDOI	immune system: hypersensitivity	70882	TAS	arthritis susceptibility
MGI:2151740	Stia2	MGI:2154506	Stia2<C57BL/6J>	MGI:2154507	Stia2<NOD/LtDOI>	involves: C57BL/6J # NOD/LtDOI	immune system: hypersensitivity	70882	TAS	arthritis susceptibility
MGI:2148669	Szs7	MGI:2154500	Szs7<DBA/2J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: seizures/epilepsy	70295	TAS	seizure susceptibility
MGI:2148670	Szs8	MGI:2154502	Szs8<DBA/2J>	MGI:2154502	Szs8<DBA/2J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: seizures/epilepsy	70295	TAS	seizure susceptibility
MGI:2148670	Szs8	MGI:2154502	Szs8<DBA/2J>	MGI:2154501	Szs8<C57BL/6J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: seizures/epilepsy	70295	TAS	seizure susceptibility
MGI:2152041	T2dm3	?	?	?	?	involves: BTBR # C57BL/6J-Lep<ob>/Lep<ob>	metabolism: abnormal glucose homeostasis	65486	TAS	insulin levels
MGI:2148649	Taste1	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	50271	TAS	saccharin preference
MGI:2148650	Taste2	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	50271	TAS	saccharin preference
MGI:1277976	Tlq1	MGI:2155122	Tlq1<M. spretus>	MGI:2155122	Tlq1<M. spretus>	involves: BALB/c # C57BL/6J # M. spretus 	no obvious phenotype: no defect detected	48933	TAS	telomere length
MGI:1277976	Tlq1	MGI:2155122	Tlq1<M. spretus>	MGI:2155124	Tlq1<BALB/c>	involves: BALB/c # C57BL/6J # M. spretus 	no obvious phenotype: no defect detected	48933	TAS	telomere length
MGI:1277976	Tlq1	MGI:2155124	Tlq1<BALB/c>	MGI:2155124	Tlq1<BALB/c>	involves: BALB/c # C57BL/6J # M. spretus 	no obvious phenotype: no defect detected	48933	TAS	telomere length
MGI:1933812	Wg1	MGI:2154524	Wg1<C57BL/6J>	?	?	involves: CAST/EiJ # C57BL/6J-Cish2<hg>/Cish2<hg>	growth/weight abnormality: postnatal	68441	TAS	weight gain
MGI:1933813	Wg2	MGI:2154526	Wg2<C57BL/6J>	?	?	involves: CAST/EiJ # C57BL/6J-Cish2<hg>/Cish2<hg>	growth/weight abnormality: postnatal	68441	TAS	weight gain
MGI:1316720	Afpq1	?	?	?	?	involves: DBA/2J # DU6i	growth/weight abnormality: postnatal	49578	TAS	adiposity
MGI:1316720	Afpq1	?	?	?	?	involves: DBA/2J # DU6i	growth/weight abnormality: postnatal	66233	TAS	adiposity
MGI:1316672	Afw1	?	?	?	?	involves: DBA/2J # DU6i	growth/weight abnormality: postnatal	49578	TAS	adiposity
MGI:1316672	Afw1	?	?	?	?	involves: DBA/2J # DU6i	growth/weight abnormality: postnatal	66233	TAS	adiposity
MGI:1330311	Alcp3	MGI:2155374	Alcp3<C57BL/6J>	MGI:2155374	Alcp3<C57BL/6J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	52086	TAS	alcohol preference
MGI:1341104	Aod2	?	?	?	?	involves: A/J # C57BL/6J 	immune system: hypersensitivity	31314	TAS	ovarian atrophy
MGI:2152433	Ap6q	MGI:2155427	Ap6q<C57BL/6J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	49707	TAS	alcohol preference
MGI:1344397	Batq2	MGI:2155576	Batq2<MH>	?	?	involves: C57BL/6J # MH	metabolism: no defect detected	55483	TAS	heat loss
MGI:2151120	Bdt2	?	?	?	?	involves: C57BL/6J # DBA/2J	skeletal: osteogenesis/developmental anomalies	69682	TAS	bone density
MGI:108562	Bglq3	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	32208	TAS	growth rate
MGI:1858764	Bh4p	?	?	?	?	involves: C57BL6/By # NZB/BlNJ	neurological/behavioral: motor capabilities/coordination/movement anomalies	53794	TAS	bar holding response
MGI:1332642	Bomb1	MGI:2155343	Bomb1<NFS/N>	?	?	involves: NFS/N # SL/Kh	tumors: no increased incidence	55364	TAS	lymphoma resistance
MGI:1332642	Bomb1	?	?	?	?	involves: NFS/N # SL/Kh	tumors: no increased incidence	16434	TAS	lymphoma resistance
MGI:2151486	Char4	MGI:2155274	Char4<C57BL/6J>	MGI:2155274	Char4<C57BL/6J>	involves: A/J # C57BL/6J 	immune system: other functional anomaly	71471	TAS	malaria resistance
MGI:2151486	Char4	MGI:2155274	Char4<C57BL/6J>	MGI:2155273	Char4<A/J>	involves: A/J # C57BL/6J 	immune system: other functional anomaly	71471	TAS	malaria resistance
MGI:2137607	Chol5	?	?	?	?	involves: C57BL/6J # KK-A<y>	metabolism: abnormal lipid homeostasis	54322	TAS	plasma cholesterol level
MGI:1891460	Cia5	MGI:2155397	Cia5<C57BL/10>	MGI:2155397	Cia5<C57BL/10>	involves: B10.RIII # RIIIS/J	immune system: hypersensitivity	50472	TAS	arthritis susceptibility
MGI:2150989	Cocrb4	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	68421	TAS	exploratory behavior
MGI:1277094	Cplaq1	?	?	?	?	involves: BALB/cBy # C57BL/6By	neurological/behavioral: sleep pattern/circadian rhythm anomalies	36675	TAS	period of locomotor activity
MGI:1098256	Daq1	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	42413	TAS	mandible morphology
MGI:1098254	Daq2	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	42413	TAS	mandible morphology
MGI:1309531	Eae10	MGI:2155435	Eae10<SJL/J>	MGI:2155435	Eae10<SJL/J>	involves: B10.S/DvTe # SJL/J	immune system: hypersensitivity	49054	TAS	EAE susceptibility
MGI:2148761	Eae20	MGI:2155282	Eae20<SJL/J>	?	?	involves: B10.S/DvTe # SJL/J	immune system: hypersensitivity	67840	TAS	demyelination
MGI:105989	Eae3	MGI:2155482	Eae3<SJL/J>	MGI:2155481	Eae3<B10.S>	involves: B10.S # SJL/J	immune system: hypersensitivity	34892	TAS	EAE susceptibility
MGI:105989	Eae3	?	?	?	?	involves: B10.RIII # RIIIS/J	immune system: hypersensitivity	26734	TAS	EAE susceptibility
MGI:2148657	Etohcta3	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	50271	TAS	conditioned taste aversion
MGI:2148658	Etohcta4	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	50271	TAS	conditioned taste aversion
MGI:1344425	Hlq3	MGI:2155351	Hlq3<MH>	?	?	involves: C57BL/6J # MH	metabolism: no defect detected	55483	TAS	heat loss
MGI:1344357	Hlq4	MGI:2155353	Hlq4<MH>	?	?	involves: C57BL/6J # MH	metabolism: no defect detected	55483	TAS	heat loss
MGI:2149993	Iba2	MGI:2155304	Iba2<A/J>	?	?	involves: A/J # C57BL/6J 	metabolism: no defect detected	65478	TAS	weight loss
MGI:1932507	Insq3	?	?	?	?	involves: A/J # SM/J	metabolism: abnormal glucose homeostasis	64138	TAS	insulin levels
MGI:1328329	Itbq1	?	?	?	?	involves: C3H/HeJ # C57BL/6J	respiratory system: no defect detected	49024	TAS	inspiratory time
MGI:1316686	Kwq2	?	?	?	?	involves: DBA/2J # DU6i	kidney/renal system: dysmorphology	49578	TAS	kidney weight
MGI:1932408	Letohc1	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	40854	TAS	alcohol aversion
MGI:2149004	Lprm2	MGI:2155325	Lprm2<MRL/MpJ>	MGI:2155325	Lprm2<MRL/MpJ>	involves: C3H/HeJ-Tnfrsf6<lpr>/Tnfrsf6<lpr> # MRL/MpJ-Tnfrsf6<lpr>/Tnfrsf6<lpr>	immune system: hypersensitivity	63511	TAS	vasculitis susceptibility
MGI:2149004	Lprm2	MGI:2155324	Lprm2<C3H/HeJ>	MGI:2155324	Lprm2<C3H/HeJ>	involves: C3H/HeJ-Tnfrsf6<lpr>/Tnfrsf6<lpr> # MRL/MpJ-Tnfrsf6<lpr>/Tnfrsf6<lpr>	immune system: hypersensitivity	44625	TAS	vasculitis susceptibility
MGI:2149004	Lprm2	MGI:2155324	Lprm2<C3H/HeJ>	MGI:2155325	Lprm2<MRL/MpJ>	involves: C3H/HeJ-Tnfrsf6<lpr>/Tnfrsf6<lpr> # MRL/MpJ-Tnfrsf6<lpr>/Tnfrsf6<lpr>	immune system: hypersensitivity	44625	TAS	vasculitis susceptibility
MGI:2148268	Lrnpcs2	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: learning/memory impairment	40226	TAS	fear response
MGI:2148582	Lrnx7	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: learning/memory impairment	65698	TAS	contextual fear response
MGI:2148582	Lrnx7	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: learning/memory impairment	43837	TAS	contextual fear response
MGI:2148810	Manh4	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	67526	TAS	mandible morphology
MGI:2148833	Manz2	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	67526	TAS	mandible size
MGI:1859912	Mord1	MGI:2155326	Mord1<C57BL/6J>	?	?	involves: BALB/cByJ # C57BL/6J-Tyr<c-2J>	eye: corneal or lens defect	62583	TAS	retina thickness
MGI:2149823	Mors2	MGI:2155392	Mors2<C57BL/6J>	?	?	involves: BALB/cJ # C57BL/6J-Lep<ob>/Lep<ob>	reproductive system: fertility/fecundity anomalies	52903	TAS	sterility
MGI:1100875	Pact1	?	?	?	?	involves: AKR/J # DBA/2J	hematology: no defect detected	43555	TAS	platelet activation
MGI:1100875	Pact1	?	?	?	?	involves: SJL/Bm # SWR/Bm	hematology: no defect detected	43555	TAS	platelet activation
MGI:2149651	Pkcal	?	?	?	?	involves: A/J # C57BL/6J 	no obvious phenotype: no defect detected	63984	TAS	protein kinase C content
MGI:2149651	Pkcal	?	?	?	?	involves: A/J # C57BL/6J 	no obvious phenotype: no defect detected	63984	TAS	protein kinase C activity
MGI:104994	Rapop3	MGI:2155516	Rapop3<BALB/cHeA>	?	?	involves: BALB/cHeA # STS/A	other aberrant phenotype	30582	TAS	apoptosis susceptibility
MGI:1347108	Scc7	?	?	?	?	involves: BALB/cHeA # STS/A	tumors: increased incidence	57235	TAS	colon tumor susceptibility
MGI:2149683	Skull4	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	53484	TAS	skull morphology
MGI:2149097	Sle11	MGI:2155328	Sle11<BXSB/J>	MGI:2155328	Sle11<BXSB/J>	involves: BXSB/J # C57BL/10Ola	immune system: hypersensitivity	60445	TAS	IgG3 level
MGI:2149097	Sle11	MGI:2155328	Sle11<BXSB/J>	MGI:2155328	Sle11<BXSB/J>	involves: BXSB/J # C57BL/10Ola	immune system: hypersensitivity	60445	TAS	antinuclear antibody production
MGI:1353463	Sles3	MGI:2155333	Sles3<NZW>	MGI:2155333	Sles3<NZW>	involves: C57BL/6 # NZW	immune system: hypersensitivity	57246	TAS	SLE resistance
MGI:2148665	Taste3	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	50271	TAS	saccharin preference
MGI:2148965	Taste7	?	?	?	?	involves: C3H/HeJ # C57BL/6J	neurological/behavioral: feeding/drinking preference anomalies	48606	TAS	bitterness sensitivity
MGI:2150672	Tbrs2	MGI:2155292	Tbrs2<C57BL/6J>	MGI:2155292	Tbrs2<C57BL/6J>	involves: C57BL/6J # DBA/2J	immune system: other functional anomaly	67658	TAS	tuberculosis resistance
MGI:2150672	Tbrs2	MGI:2155292	Tbrs2<C57BL/6J>	MGI:2155293	Tbrs2<DBA/2J>	involves: C57BL/6J # DBA/2J	immune system: other functional anomaly	67658	TAS	tuberculosis resistance
MGI:1345631	Tbs1	?	?	?	?	involves: A/SnYCit # I/StSnEgYCit	immune system: no defect detected	55857	TAS	weight loss
MGI:105989	Tmevd2	?	?	?	?	(BALB/cByJ x DBA/2J)F1 x BALB/cByJ	immune system: hypersensitivity	43978	TAS	Theiler's murine encephalomyelitis susceptibility
MGI:1344339	Wt10q2	?	?	?	?	involves: C57BL/6J # MH	growth/weight abnormality: postnatal	55483	TAS	body weight
MGI:1196361	Aaiq1	?	?	?	?	(C57BL/6J x A/J)F1 x A/J	no obvious phenotype: no defect detected	44129	TAS	aromatase activity
MGI:1196363	Aaiq2	?	?	?	?	(C57BL/6J x A/J)F1 x A/J	no obvious phenotype: no defect detected	44129	TAS	aromatase activity
MGI:2151891	Adaz1	MGI:2155606	Adaz1<NZM2328/J>	MGI:2155606	Adaz1<NZM2328/J>	involves: C57L/J # NZM2328/J	immune system: hypersensitivity	71397	TAS	anti-dsDNA antibody production
MGI:1316710	Afpq2	?	?	?	?	involves: DU6i # DUKs	growth/weight abnormality: postnatal	49578	TAS	adiposity
MGI:1316710	Afpq2	?	?	?	?	involves: DBA/2J # DU6i	growth/weight abnormality: postnatal	66233	TAS	adiposity
MGI:1316673	Afw2	?	?	?	?	involves: DU6i # DUKs	growth/weight abnormality: postnatal	49578	TAS	adiposity
MGI:1316673	Afw2	?	?	?	?	involves: DBA/2J # DU6i	growth/weight abnormality: postnatal	66233	TAS	adiposity
MGI:2150757	Alan2	MGI:2155721	Alan2<B10.O20/Dem>	MGI:2155721	Alan2<B10.O20/Dem>	involves: B10.O20/Dem # O20/A	immune system: hypersensitivity	67657	TAS	alloantigen response
MGI:2150757	Alan2	MGI:2155721	Alan2<B10.O20/Dem>	MGI:2155722	Alan2<O20/A>	involves: B10.O20/Dem # O20/A	immune system: hypersensitivity	67657	TAS	alloantigen response
MGI:1858456	Alcp7	?	?	?	?	multiple	neurological/behavioral: feeding/drinking preference anomalies	52467	TAS	alcohol preference
MGI:1858457	Alcp8	?	?	?	?	multiple	neurological/behavioral: feeding/drinking preference anomalies	52467	TAS	alcohol preference
MGI:1309537	Alcw2	MGI:2155928	Alcw2<DBA/2J>	MGI:2155928	Alcw2<DBA/2J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	40532	TAS	alcohol withdrawal
MGI:1309537	Alcw2	MGI:2155928	Alcw2<DBA/2J>	MGI:2155928	Alcw2<DBA/2J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	40532	TAS	alcohol withdrawal
MGI:1309537	Alcw2	MGI:2155928	Alcw2<DBA/2J>	MGI:2155928	Alcw2<DBA/2J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	40532	TAS	alcohol withdrawal
MGI:2151074	Amp1	MGI:2155697	Amp1<C57BL/6J>	MGI:2155697	Amp1<C57BL/6J>	involves: BALB/cJ # C57BL/6J	neurological/behavioral: sleep pattern/circadian rhythm anomalies	69972	TAS	circadian rhythm
MGI:2152430	Ap3q	MGI:2155848	Ap3q<C57BL/6J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	49707	TAS	alcohol preference
MGI:2149546	Arvm1	MGI:2155751	Arvm1<MRL/MpJ>	MGI:2155751	Arvm1<MRL/MpJ>	involves: C3H/HeJ-Tnfrsf6<lpr>/Tnfrsf6<lpr> # MRL/MpJ-Tnfrsf6<lpr>	immune system: hypersensitivity	63511	TAS	vasculitis susceptibility
MGI:2149547	Arvm2	MGI:2155753	Arvm2<MRL/MpJ>	MGI:2155753	Arvm2<MRL/MpJ>	involves: C3H/HeJ-Tnfrsf6<lpr>/Tnfrsf6<lpr> # MRL/MpJ-Tnfrsf6<lpr>	immune system: hypersensitivity	63511	TAS	vasculitis susceptibility
MGI:2150643	Asm2	?	?	?	?	involves: C3H/HeJ-Tnfrsf6<lpr>/Tnfrsf6<lpr> # MRL/MpJ-Tnfrsf6<lpr>/Tnfrsf6<lpr>	immune system: hypersensitivity	66459	TAS	sialadenitis susceptibility
MGI:1933987	Athsq1	MGI:2155675	Athsq1<MOLF/Ei>	MGI:2155675	Athsq1<MOLF/Ei>	involves: B6.129S7-Ldlr<tm1Her> # C57BL/6J-Ldlr<tm1Her> # MOLF/Ei	heart/cardiovascular system: other functional anomalies	70259	TAS	atherosclerosis susceptibility
MGI:1933987	Athsq1	MGI:2155675	Athsq1<MOLF/Ei>	MGI:2155676	Athsq1<C57BL/6J	involves: B6.129S7-Ldlr<tm1Her> # C57BL/6J-Ldlr<tm1Her> # MOLF/Ei	heart/cardiovascular system: other functional anomalies	70259	TAS	atherosclerosis susceptibility
MGI:2148559	Axtlm	?	?	?	?	(H1 x L1)F2	neurological/behavioral: fear/anxiety	69668	TAS	locomotor activity
MGI:2148559	Axtlm	?	?	?	?	(H2 x L2)F2	neurological/behavioral: fear/anxiety	69668	TAS	locomotor activity
MGI:2148545	Axtofa2	?	?	?	?	(H1 x L1)F2	neurological/behavioral: fear/anxiety	70479	TAS	open field activity
MGI:2148545	Axtofa2	?	?	?	?	(H2 x L2)F2	neurological/behavioral: fear/anxiety	70479	TAS	open field activity
MGI:2149350	Bbaa1	MGI:2155831	Bbaa1<C3H/HeNCr>	MGI:2155831	Bbaa1<C3H/HeNCr>	involves: C3H/HeNCr # C57BL/6NCr	immune system: hypersensitivity	52017	TAS	ankle swelling
MGI:2149350	Bbaa1	MGI:2155831	Bbaa1<C3H/HeNCr>	MGI:2155832	Bbaa1<C57BL/6NCr>	involves: C3H/HeNCr # C57BL/6NCr	immune system: hypersensitivity	52017	TAS	ankle swelling
MGI:108558	Bgeq3	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	32208	TAS	growth rate
MGI:108558	Bgeq3	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	60662	TAS	growth rate
MGI:108557	Bglq4	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	32208	TAS	growth rate
MGI:108557	Bglq4	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	60662	TAS	growth rate
MGI:1891315	Bpq3	?	?	?	?	involves: A/J # C57BL/6J 	heart/cardiovascular system: no defect detected	66987	TAS	blood pressure
MGI:2151806	Bulb1	?	?	?	?	involves: C57BL/6J # DBA/2J	central nervous system: other dysmorphology	71082	TAS	olfactory bulb size
MGI:2151806	Bulb1	?	?	?	?	multiple	central nervous system: other dysmorphology	71082	TAS	olfactory bulb size
MGI:1316684	Bw7	?	?	?	?	involves: DU6i # DUKs	growth/weight abnormality: postnatal	49578	TAS	body weight
MGI:1316684	Bw7	?	?	?	?	involves: DBA/2J # DU6i	growth/weight abnormality: postnatal	66233	TAS	body weight
MGI:1298203	Bwq1	MGI:2155864	Bwq1<KK>	?	?	involves: C57BL/6J # KK-A<y>	growth/weight abnormality: postnatal	48704	TAS	body weight
MGI:1891194	Bwtq2	?	?	?	?	involves: C57BL/6J # DBA/2J	growth/weight abnormality: postnatal	53812	TAS	body weight
MGI:2150828	Cafq2	?	?	?	?	involves: APN # C3H/HeJ	metabolism: no defect detected	68139	TAS	caffeine metabolism
MGI:2148996	Ccrs2	MGI:2155837	Ccrs2<NZB/BlNj>	MGI:2155837	Ccrs2<NZB/BlNj>	involves: C57BL/6By # NZB/BlNJ	central nervous system: other dysmorphology	51052	TAS	brain morphology
MGI:2148996	Ccrs2	MGI:2155837	Ccrs2<NZB/BlNj>	MGI:2155836	Ccrs2<C57BL/6By>	involves: C57BL/6By # NZB/BlNJ	central nervous system: other dysmorphology	51052	TAS	brain morphology
MGI:2148996	Ccrs2	MGI:2155836	Ccrs2<C57BL/6By>	MGI:2155836	Ccrs2<C57BL/6By>	involves: C57BL/6By # NZB/BlNJ	central nervous system: other dysmorphology	51052	TAS	brain morphology
MGI:1346025	Cms1	MGI:2155782	Cms1<DBA/2J>	?	?	involves: C57BL/6J # DBA/2J	immune system: no defect detected	55132	TAS	Coccidioides immitis resistance
MGI:1346025	Cms1	MGI:2155782	Cms1<DBA/2J>	?	?	involves: C57BL/6J # DBA/2J	immune system: no defect detected	55132	TAS	Coccidioides immitis resistance
MGI:2150991	Cocrb5	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	68421	TAS	repeated movements
MGI:99952	Dob1	MGI:2155966	Dob1<AKR/J>	MGI:2155966	Dob1<AKR/J>	involves: AKR/J # SWR/J	growth/weight abnormality: postnatal	20129	TAS	obesity
MGI:99952	Dob1	MGI:2155966	Dob1<AKR/J>	MGI:2155967	Dob1<SWR/J>	involves: AKR/J # SWR/J	growth/weight abnormality: postnatal	20129	TAS	obesity
MGI:2152560	Dyscalc2	MGI:2155601	Dyscalc2<C57BL/6J>	MGI:2155601	Dyscalc2<C57BL/6J>	involves: C3H/HeJ # C57BL/6J	heart/cardiovascular system: dysmorphology	72021	TAS	cardiac calcinosis resistance
MGI:2152560	Dyscalc2	MGI:2155603	Dyscalc2<C3H/HeJ>	MGI:2155601	Dyscalc2<C57BL/6J>	involves: C3H/HeJ # C57BL/6J	heart/cardiovascular system: dysmorphology	72021	TAS	cardiac calcinosis resistance
MGI:2152560	Dyscalc2	MGI:2155603	Dyscalc2<C3H/HeJ>	MGI:2155603	Dyscalc2<C3H/HeJ>	involves: C3H/HeJ # C57BL/6J	heart/cardiovascular system: dysmorphology	72021	TAS	cardiac calcinosis susceptibility
MGI:1346097	Estq1	?	?	?	?	involves: C3H/HeJ # C57BL/6J	immune system: no defect detected	53494	TAS	leukocyte infiltration	
MGI:2148659	Etohcta5	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	50271	TAS	conditioned taste aversion	
MGI:1098216	Faq1	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	42413	TAS	mandible morphology	
MGI:1329007	Fecq2	MGI:2155910	Fecq2<QSo>	MGI:2155910	Fecq2<QSo>	involves: C57BL/6J # Qso	reproductive system: fertility/fecundity anomalies	44163	TAS	litter size	
MGI:1329007	Fecq2	MGI:2155910	Fecq2<QSo>	MGI:2155909	Fecq2<C57BL/6J>	involves: C57BL/6J # Qso	reproductive system: fertility/fecundity anomalies	44163	TAS	litter size	
MGI:2151076	Frp1	MGI:2155698	Frp1<C57BL/6J>	MGI:2155698	Frp1<C57BL/6J>	involves: BALB/cJ # C57BL/6J	neurological/behavioral: sleep pattern/circadian rhythm anomalies	69972	TAS	free running period	
MGI:2151076	Frp1	MGI:2155698	Frp1<C57BL/6J>	MGI:2155699	Frp1<BALB/cJ>	involves: BALB/cJ # C57BL/6J	neurological/behavioral: sleep pattern/circadian rhythm anomalies	69972	TAS	free running period	
MGI:2151076	Frp1	MGI:2155699	Frp1<BALB/cJ>	MGI:2155699	Frp1<BALB/cJ>	involves: BALB/cJ # C57BL/6J	neurological/behavioral: sleep pattern/circadian rhythm anomalies	69972	TAS	free running period	
MGI:1346075	Gasa1	MGI:2155784	Gasa1<BALB/cCrSlc>	MGI:2155784	Gasa1<BALB/cCrSlc>	involves: BALB/cCrSlc # C57BL/6	immune system: hypersensitivity	54699	TAS	gastritis susceptibility/resistance	
MGI:1346059	Gasa2	MGI:2155786	Gasa2<BALB/cCrSlc>	MGI:2155786	Gasa2<BALB/cCrSlc>	involves: BALB/cCrSlc # C57BL/6	immune system: hypersensitivity	54699	TAS	gastritis susceptibility/resistance	
MGI:1346067	Gvhd2	MGI:2155826	Gvhd2<C57BL/10J>	MGI:2155826	Gvhd2<C57BL/10J>	involves: B10.D2-H2<d> # DBA/2J	immune system: hypersensitivity	52834	TAS	splenomegaly	
MGI:2149679	Im2	MGI:2157092	Im2<ABH>	?	?	involves: ABH # ABL	immune system: no defect detected	65671	TAS	antibody response	
MGI:105967	Imh1	MGI:2155943	Imh1<NZB>	MGI:2155943	Imh1<NZB>	involves: NZB # NZW	immune system: other functional anomaly	22353	TAS	hypergammaglobulinemia 	
MGI:105967	Imh1	MGI:2155943	Imh1<NZB>	MGI:2155944	Imh1<NZW>	involves: NZB # NZW	immune system: other functional anomaly	22353	TAS	hypergammaglobulinemia 	
MGI:105966	Imm1	MGI:2155947	Imm1<NZW>	MGI:2155947	Imm1<NZW>	involves: NZB # NZW	immune system: other functional anomaly	26266	TAS	hypergammaglobulinemia 	
MGI:105966	Imm1	MGI:2155947	Imm1<NZW>	MGI:2155946	Imm1<NZB>	involves: NZB # NZW	immune system: other functional anomaly	26266	TAS	hypergammaglobulinemia 	
MGI:1889219	Insq1	?	?	?	?	involves: DBA/2J # DU6i	metabolism: abnormal glucose homeostasis	66233	TAS	insulin level
MGI:105965	Lbw2	MGI:2155968	Lbw2<NZB>	MGI:2155968	Lbw2<NZB>	involves: NZB # NZW	immune system: hypersensitivity	20991	TAS	glomerulonephritis
MGI:105965	Lbw2	MGI:2155968	Lbw2<NZB>	MGI:2155969	Lbw2<NZW>	involves: NZB # NZW	immune system: hypersensitivity	20991	TAS	glomerulonephritis
MGI:105965	Lbw2	MGI:2155968	Lbw2<NZB>	MGI:2155968	Lbw2<NZB>	involves: NZB # NZW	immune system: hypersensitivity	20991	TAS	mortality
MGI:105965	Lbw2	MGI:2155968	Lbw2<NZB>	MGI:2155969	Lbw2<NZW>	involves: NZB # NZW	immune system: hypersensitivity	20991	TAS	mortality
MGI:1203738	Lmb1	MGI:2155873	Lmb1<C57BL/6>	?	?	involves: C57BL/6-Tnfrsf6<lpr> # MRL-Tnfrsf6<lpr>	immune system: hypersensitivity	45708	TAS	splenomegaly
MGI:1203738	Lmb1	MGI:2155873	Lmb1<C57BL/6>	?	?	involves: C57BL/6-Tnfrsf6<lpr> # MRL-Tnfrsf6<lpr>	immune system: hypersensitivity	45708	TAS	lymphoadenopathy
MGI:1203738	Lmb1	MGI:2155873	Lmb1<C57BL/6>	?	?	involves: C57BL/6-Tnfrsf6<lpr> # MRL-Tnfrsf6<lpr>	immune system: hypersensitivity	45708	TAS	anti-dsDNA antibody production
MGI:2149003	Lprm1	MGI:2155879	Lprm1<MRL/MpJ>	MGI:2155879	Lprm1<MRL/MpJ>	involves: C3H/HeJ-Tnfrsf6<lpr>/Tnfrsf6<lpr> # MRL/MpJ-Tnfrsf6<lpr>/Tnfrsf6<lpr>	immune system: hypersensitivity	44625	TAS	vasculitis susceptibility
MGI:1316739	Lwq1	?	?	?	?	involves: DU6i # DUKs	liver/hepatic system: dysmorphology	49578	TAS	liver weight
MGI:1316739	Lwq1	?	?	?	?	involves: DBA/2J # DU6i	liver/hepatic system: dysmorphology	66233	TAS	liver weight
MGI:2148812	Manh5	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	67526	TAS	mandible morphology
MGI:2148834	Manz3	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	67526	TAS	mandible size
MGI:1890550	Mmtg1	?	?	?	?	FVB/NJ X (I/LnJ X FVB/NMul-TgN(MMTVPyVT)<634mul>)F1	tumors: increased incidence	70229	TAS	tumor growth
MGI:1890551	Mmtg2	?	?	?	?	FVB/NJ X (I/LnJ X FVB/NMul-TgN(MMTVPyVT)<634mul>)F1	tumors: increased incidence	70229	TAS	tumor growth
MGI:1203739	Mpsq1	?	?	?	?	multiple	immune system: other functional anomaly	44588	TAS	Mycoplasma pulmonis susceptibility
MGI:1277966	Nidd1	MGI:2155870	Nidd1<NON/LtHl>	MGI:2155870	Nidd1<NON/LtHl>	involves: NON/LtH1 # NZO/H1	metabolism: abnormal glucose homeostasis	48957	TAS	diabetes susceptibility
MGI:1277966	Nidd1	MGI:2155870	Nidd1<NON/LtHl>	MGI:2155871	Nidd1<NZO/Hl>	involves: NON/LtH1 # NZO/H1	metabolism: abnormal glucose homeostasis	48957	TAS	diabetes susceptibility
MGI:1277966	Nidd1	MGI:2155871	Nidd1<NZO/Hl>	MGI:2155871	Nidd1<NZO/Hl>	involves: NON/LtH1 # NZO/H1	growth/weight abnormality: postnatal	48957	TAS	body weight
MGI:1277966	Nidd1	MGI:2155871	Nidd1<NZO/Hl>	MGI:2155871	Nidd1<NZO/Hl>	involves: NON/LtH1 # NZO/H1	metabolism: abnormal glucose homeostasis	48957	TAS	insulin level
 MGI:2137388	Pabr2	?	?	?	?	(B6HuBTg x 129X1/SvJ)F2	metabolism: abnormal lipid homeostasis	69759	TAS	plasma apoB level
 MGI:2137388	Pabr2	?	?	?	?	(B6HuBTg x 129X1/SvJ)F1 x C57BL/6J	metabolism: abnormal lipid homeostasis	69759	TAS	plasma apoB level
 MGI:2137388	Pabr2	?	?	?	?	(B6HuBTg x129X1/SvJ)F1 x 129X1/SvJ	metabolism: abnormal lipid homeostasis	69759	TAS	plasma apoB level
MGI:1345292	Pas9	MGI:2155668	Pas9<BALB/cOlaHsd>	?	?	involves: A/JO1aHsd # BALB/cOlaHsd	tumors: increased incidence	50533	TAS	lung tumor susceptibility
MGI:2149334	Pgia13	MGI:2155748	Pgia13<C3H/HeJCr>	MGI:2155748	Pgia13<C3H/HeJCr>	involves: C3H/HeJCr # C57BL/6	immune system: hypersensitivity	65424	TAS	arthritis onset
MGI:2151896	Pitm2	MGI:2155692	Pitm2<C57BL/FaDk>	MGI:2155692	Pitm2<C57BL/FaDk>	involves: C57BL/FaDk # RIII/FaDk	central nervous system: other functional anomalies	70033	TAS	prion incubation time
MGI:2151896	Pitm2	MGI:2155692	Pitm2<C57BL/FaDk>	MGI:2155693	Pitm2<RIII/FaDk>	involves: C57BL/FaDk # RIII/FaDk	central nervous system: other functional anomalies	70033	TAS	prion incubation time
MGI:2151896	Pitm2	MGI:2155693	Pitm2<RIII/FaDk>	MGI:2155693	Pitm2<RIII/FaDk>	involves: C57BL/FaDk # RIII/FaDk	central nervous system: other functional anomalies	70033	TAS	prion incubation time
MGI:2155670	Ramt1	?	?	?	?	involves: C57BL/6J # SPRET/Ei	tumors: increased incidence	72671	TAS	LOH
MGI:2137672	Remslp1	?	?	?	?	multiple	neurological/behavioral: sleep pattern/circadian rhythm anomalies	61416	TAS	24 REM
MGI:2137672	Remslp1	?	?	?	?	multiple	neurological/behavioral: sleep pattern/circadian rhythm anomalies	61416	TAS	dark phase REM
MGI:105964	Sbw2	MGI:2155971	Sbw2<NZB>	MGI:2155971	Sbw2<NZB>	involves: NZB # NZW	immune system: hypersensitivity	20991	TAS	splenomegaly
MGI:105964	Sbw2	MGI:2155971	Sbw2<NZB>	MGI:2155970	Sbw2<NZW>	involves: NZB # NZW	immune system: hypersensitivity	20991	TAS	splenomegaly
MGI:1351479	Skts7	MGI:2155770	Skts7<NIH/Ola>	?	?	involves: M. spretus # NIH/Ola	tumors: increased incidence	59049	TAS	skin tumor susceptibility
MGI:2149685	Skull5	MGI:2155805	Skull5<LG/J>	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	53484	TAS	skull morphology
MGI:2149686	Skull6	MGI:2155807	Skull6<LG/J>	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	53484	TAS	skull morphology
MGI:105963	Sle2	MGI:2155957	Sle2<NZM/Aeg2410>	MGI:2155957	Sle2<NZM/Aeg2410>	involves: C57BL/6J # NZM/Aeg2410	immune system: hypersensitivity	25006	TAS	glomerulonephritis
MGI:1353462	Sles2	MGI:2155793	Sles2<NZW>	MGI:2155793	Sles2<NZW>	involves: C57BL/6 # NZW	immune system: hypersensitivity	57246	TAS	SLE resistance
MGI:1335085	Sluc6	?	?	?	?	involves: B10.O20/Dem # O20/A	tumors: increased incidence	50525	TAS	lung tumor susceptibility
MGI:2137854	Spm1	MGI:2155767	Spm1<C57BL/6>	?	?	involves: C57BL/6 # NZB	immune system: hypersensitivity	59427	TAS	splenomegaly
MGI:1343153	Sporl1	MGI:2155780	Sporl1<STS/A>	?	?	involves: B10.O20/Dem # O20/A	immune system: lymphoid development/ B lymphocyte defects	56029	TAS	lymphocyte proliferation
MGI:1858758	Start1	?	?	?	?	involves: C57BL/6By # NZB/BlNJ	neurological/behavioral: sensory capabilities/reflexes/nociception abnormalities	53794	TAS	startle response
MGI:1858759	Start2	?	?	?	?	involves: C57BL/6By # NZB/BlNJ	neurological/behavioral: sensory capabilities/reflexes/nociception abnormalities	53794	TAS	startle response
MGI:1098816	Szs2	MGI:2155930	Szs2<C57BL/6J>	MGI:2155930	Szs2<C57BL/6J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: seizures/epilepsy	38888	TAS	seizure susceptibility
MGI:1098816	Szs2	MGI:2155930	Szs2<C57BL/6J>	MGI:2155931	Szs2<DBA/2J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: seizures/epilepsy	38888	TAS	seizure susceptibility
MGI:1932203	Tafat	MGI:2155688	Tafat<TH>	MGI:2155688	Tafat<TH>	involves: C57BL/6J # TH	growth/weight abnormality: postnatal	70227	TAS	adiposity
MGI:1932203	Tafat	MGI:2155688	Tafat<TH>	MGI:2155688	Tafat<TH>	involves: CAST/Ei # TH	growth/weight abnormality: postnatal	70227	TAS	adiposity
MGI:2148666	Taste4	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	50271	TAS	saccharin preference
MGI:2151619	Thyls	MGI:2155608	Thyls<BALB/c>	MGI:2155608	Thyls<BALB/c>	involves: BALB/c # MSM	tumors: increased incidence	71358	TAS	thymic lymphoma susceptibility
MGI:2151619	Thyls	MGI:2155608	Thyls<BALB/c>	MGI:2155609	Thyls<MSM>	involves: BALB/c # MSM	tumors: increased incidence	71358	TAS	thymic lymphoma susceptibility
MGI:106224	Tlsr1	?	?	?	?	involves: BALB/cJ # C57BL/6J	tumors: increased incidence	56600	TAS	LOH
MGI:106224	Tlsr1	?	?	?	?	involves: C57BL/6J # RF/J	tumors: increased incidence	31797	TAS	LOH
MGI:106223	Tlsr2	?	?	?	?	involves: C57BL/6J # RF/J	tumors: increased incidence	31797	TAS	LOH
MGI:106223	Tlsr2	?	?	?	?	involves: BALB/cJ # C57BL/6J	tumors: increased incidence	49558	TAS	LOH
MGI:1313309	Tlsr3	?	?	?	?	involves: BALB/cJ # C57BL/6J	tumors: increased incidence	49558	TAS	LOH
MGI:1345498	Tlsr4	?	?	?	?	involves: BALB/cJ # C57BL/6J	tumors: increased incidence	56600	TAS	LOH
MGI:1345499	Tlsr5	?	?	?	?	involves: BALB/cJ # C57BL/6J	tumors: increased incidence	56600	TAS	LOH
MGI:1345499	Tlsr5	?	?	?	?	involves: C57BL/6J # RF/J	tumors: increased incidence	56600	TAS	LOH
MGI:2137709	Tpnr1	MGI:2155914	Tpnr1<C57BL/6J>	MGI:2155914	Tpnr1<C57BL/6J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: sensory capabilities/reflexes/nociception abnormalities	40544	TAS	pain sensitivity
MGI:2137709	Tpnr1	MGI:2155914	Tpnr1<C57BL/6J>	MGI:2155915	Tpnr1<DBA/2J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: sensory capabilities/reflexes/nociception abnormalities	40544	TAS	pain sensitivity
MGI:2137709	Tpnr1	MGI:2155915	Tpnr1<DBA/2J>	MGI:2155915	Tpnr1<DBA/2J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: sensory capabilities/reflexes/nociception abnormalities	40544	TAS	pain sensitivity
MGI:1932519	Triglq1	MGI:2155750	Triglq1<SM/J>	?	?	involves: A/J # SM/J	metabolism: abnormal lipid homeostasis	64138	TAS	plasma triglyceride level
MGI:2149058	Wta1	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	62610	TAS	body weight
MGI:2153658	Mopkd1	?	?	?	?	(DBA/2 x CAST/Ei)F2-pcy/pcy	kidney/renal system: dysmorphology	44580	TAS	kidney/body weight ratio
MGI:2150031	Actd2	MGI:2156055	Actd2<C57BL/6J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: motor capabilities/coordination/movement anomalies	65696	TAS	locomotor activity
MGI:2150032	Actd3	MGI:2156058	Actd3<C57BL/6J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: motor capabilities/coordination/movement anomalies	65696	TAS	locomotor activity
MGI:1858757	Aeyo	MGI:2156123	Aeyo<C57BL/6By>	MGI:2156123	Aeyo<C57BL/6By>	involves: C57BL6/By # NZB/BlNJ	growth/weight abnormality: postnatal	53794	TAS	eyelid opening
MGI:1858757	Aeyo	MGI:2156123	Aeyo<C57BL/6By>	MGI:2156125	Aeyo<NZB/BlNJ>	involves: C57BL6/By # NZB/BlNJ	growth/weight abnormality: postnatal	53794	TAS	eyelid opening
MGI:1858757	Aeyo	MGI:2156125	Aeyo<NZB/BlNJ>	MGI:2156125	Aeyo<NZB/BlNJ>	involves: C57BL6/By # NZB/BlNJ	growth/weight abnormality: postnatal	53794	TAS	eyelid opening
MGI:1316709	Afpq3	?	?	?	?	involves: DU6 # DUKs	growth/weight abnormality: postnatal	49578	TAS	adiposity
MGI:1316674	Afw3	?	?	?	?	involves: DU6 # DUKs	growth/weight abnormality: postnatal	49578	TAS	adiposity
MGI:1316674	Afw3	MGI:2156040	Afw3<DU6i>	?	?	involves: DBA/2J # DU6i	growth/weight abnormality: postnatal	66233	TAS	adiposity
MGI:1858389	Alcp10	?	?	?	?	involves: A/J # C57BL/6J 	neurological/behavioral: feeding/drinking preference anomalies	52467	TAS	alcohol preference
MGI:1858458	Alcp9	?	?	?	?	involves: A/J # C57BL/6J 	neurological/behavioral: feeding/drinking preference anomalies	52467	TAS	alcohol preference
MGI:2149351	Bbaa2	MGI:2156192	Bbaa2<C3H/HeNCr>	MGI:2156192	Bbaa2<C3H/HeNCr>	involves: C3H/HeNCr # C57BL/6NCr	immune system: no defect detected	52017	TAS	ankle swelling
MGI:2149352	Bbaa3	MGI:2156195	Bbaa3<C3H/HeNCr>	MGI:2156195	Bbaa3<C3H/HeNCr>	involves: C3H/HeNCr # C57BL/6NCr	immune system: no defect detected	52017	TAS	histopathology
MGI:2149352	Bbaa3	MGI:2156195	Bbaa3<C3H/HeNCr>	MGI:2156195	Bbaa3<C3H/HeNCr>	involves: C3H/HeNCr # C57BL/6NCr	immune system: no defect detected	52017	TAS	tendon sheath thickness
MGI:1932348	Bglq14	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	60662	TAS	growth rate
MGI:1349433	Bmd2	MGI:2156068	Bmd2<C57BL/6J>	MGI:2156068	Bmd2<C57BL/6J>	involves: CAST/Ei # C57BL/6J	skeletal: osteogenesis/developmental anomalies	58152	TAS	bone density
MGI:1349433	Bmd2	MGI:2156068	Bmd2<C57BL/6J>	MGI:2156069	Bmd2<CAST/Ei>	involves: CAST/Ei # C57BL/6J	skeletal: osteogenesis/developmental anomalies	58152	TAS	bone density
MGI:1891316	Bpq4	?	?	?	?	involves: A/J # C57BL/6J	heart/cardiovascular system: no defect detected	66987	TAS	blood pressure
MGI:1889214	Bw13	MGI:2156045	Bw13<DU6i>	?	?	involves: DBA/2J # DU6i	growth/weight abnormality: postnatal	66233	TAS	body weight
MGI:1316643	Bw8	?	?	?	?	involves: DU6 # DUKs	growth/weight abnormality: postnatal	49578	TAS	body weight
MGI:1858760	Bwefm	MGI:2156130	Bwefm<NZB/BlNJ>	MGI:2156130	Bwefm<NZB/BlNJ>	involves: C57BL/6By # NZB/BlNJ	growth/weight abnormality: postnatal	53794	TAS	body weight
MGI:1858760	Bwefm	MGI:2156130	Bwefm<NZB/BlNJ>	MGI:2156128	Bwefm<C57BL/6By>	involves: C57BL/6By # NZB/BlNJ	growth/weight abnormality: postnatal	53794	TAS	body weight
MGI:1858760	Bwefm	MGI:2156128	Bwefm<C57BL/6By>	MGI:2156128	Bwefm<C57BL/6By>	involves: C57BL/6By # NZB/BlNJ	growth/weight abnormality: postnatal	53794	TAS	body weight
MGI:1858761	Bwem1	MGI:2156134	Bwem1<NZB/BlNJ>	MGI:2156134	Bwem1<NZB/BlNJ>	involves: C57BL/6By # NZB/BlNJ	growth/weight abnormality: postnatal	53794	TAS	body weight
MGI:1858761	Bwem1	MGI:2156134	Bwem1<NZB/BlNJ>	MGI:2156132	Bwem1<C57BL/6By>	involves: C57BL/6By # NZB/BlNJ	growth/weight abnormality: postnatal	53794	TAS	body weight
MGI:1858761	Bwem1	MGI:2156132	Bwem1<C57BL/6By>	MGI:2156132	Bwem1<C57BL/6By>	involves: C57BL/6By # NZB/BlNJ	growth/weight abnormality: postnatal	53794	TAS	body weight
MGI:2149826	Bwob	?	?	?	?	involves: BALB/cJ # C57BL/6J-Lep<ob>/Lep<ob> 	growth/weight abnormality: postnatal	52903	TAS	body weight
MGI:1933824	Carf1	MGI:2156016	Carf1<CAST/EiJ>	?	?	involves: CAST/EiJ # C57BL/6J-hg/hg	growth/weight abnormality: postnatal	68441	TAS	adiposity
MGI:2150992	Cocrb6	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	68421	TAS	locomotor activity
MGI:2150992	Cocrb6	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	68421	TAS	exploratory behavior
MGI:2150992	Cocrb6	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	68421	TAS	repeated movements
MGI:2151922	Cpfd3	MGI:2155992	Cpfd3<NZB/BlNJ>	?	?	involves: C57BL/6By # NZB/BlNJ	central nervous system: other dysmorphology	71085	TAS	brain morphology
MGI:1277144	Cplaq5	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: sleep pattern/circadian rhythm anomalies	29803	TAS	period of locomotor activity
MGI:1277147	Cplaq6	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: sleep pattern/circadian rhythm anomalies	29803	TAS	period of locomotor activity
MGI:1098255	Daq3	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	42413	TAS	mandible morphology
MGI:2149844	Dbsty2	MGI:2156063	Dbsty2<NZO/HlLt>	MGI:2156063	Dbsty2<NZO/HlLt>	involves: NON/Lt # NZO/HlLt 	growth/weight abnormality: postnatal	65256	TAS	adiposity
MGI:2149844	Dbsty2	MGI:2156063	Dbsty2<NZO/HlLt>	MGI:2156062	Dbsty2<NON/Lt>	involves: NON/Lt # NZO/HlLt 	growth/weight abnormality: postnatal	65256	TAS	adiposity
MGI:2150993	Drb1	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	68421	TAS	dopamine receptor binding
MGI:2150994	Drb2	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	68421	TAS	dopamine receptor binding
MGI:1345666	Dssc1	MGI:2156163	Dssc1<C57BL/6J>	?	?	involves: C3H/HeJ # C57BL/6J	immune system: hypersensitivity	52852	TAS	colitis severity
MGI:1345666	Dssc1	MGI:2156163	Dssc1<C57BL/6J>	?	?	involves: C3H/HeJ # C57BL/6J	immune system: hypersensitivity	52852	TAS	colon hyperplasia
MGI:1345666	Dssc1	MGI:2156163	Dssc1<C57BL/6J>	?	?	involves: C3H/HeJ # C57BL/6J	immune system: hypersensitivity	52852	TAS	colon ulceration
MGI:1345666	Dssc1	MGI:2156163	Dssc1<C57BL/6J>	?	?	involves: C3H/HeJ # C57BL/6J	immune system: hypersensitivity	52852	TAS	colitis % area affected
MGI:2151843	Elmaz1	MGI:2155993	Elmaz1<A/J>	?	?	involves: A/J-Tyr<c>/Tyr<c> # CBA/J-Pde6b<rdl>/Pde6b<rdl>	neurological/behavioral: motor capabilities/coordination/movement anomalies	70379	TAS	exploratory behavior
MGI:2151844	Elmaz2	MGI:2155996	Elmaz2<CBA/J>	?	?	involves: A/J-Tyr<c>/Tyr<c> # CBA/J-Pde6b<rdl>/Pde6b<rdl>	neurological/behavioral: motor capabilities/coordination/movement anomalies	70379	TAS	exploratory behavior
MGI:1346095	Estq2	MGI:2156161	Estq2<C57BL/6J>	?	?	involves: C3H/HeJ # C57BL/6J	reproductive system: dysmorphology	52898	TAS	uterine weight
MGI:1336889	Eye1	MGI:2156116	Eye1<DBA/2J>	MGI:2156116	Eye1<DBA/2J>	involves: C57BL/6J # DBA/2J	eye: no defect detected	53890	TAS	eye weight
MGI:1336889	Eye1	MGI:2156116	Eye1<DBA/2J>	MGI:2156115	Eye1<C57BL/6J>	involves: C57BL/6J # DBA/2J	eye: no defect detected	53890	TAS	eye weight
MGI:1098217	Faq2	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	42413	TAS	mandible morphology
MGI:2151078	Frp2	MGI:2156000	Frp2<C57BL/6J>	MGI:2156000	Frp2<C57BL/6J>	involves: BALB/cJ # C57BL/6J	neurological/behavioral: sleep pattern/circadian rhythm anomalies	69972	TAS	free running period
MGI:2151078	Frp2	MGI:2156000	Frp2<C57BL/6J>	MGI:2155999	Frp2<BALB/cJ>	involves: BALB/cJ # C57BL/6J	neurological/behavioral: sleep pattern/circadian rhythm anomalies	69972	TAS	free running period
MGI:99635	Hcs5	MGI:2155988	Hcs5<C3H/He>	?	?	involves: C3H/He # C57BL/6JBy # M. spretus	tumors: increased incidence	20738	TAS	liver cancer susceptibility
MGI:2149552	Hdl2	?	?	?	?	involves: C57BL/6J # CAST/Ei	metabolism: abnormal lipid homeostasis	66421	TAS	plasma HDL level
MGI:2151184	Hipp2	MGI:2156001	Hipp2<C57BL/6J>	?	?	involves: C57BL/6J # DBA/2J	central nervous system: no defect detected	69261	TAS	hippocampus weight
MGI:1890582	Hpi2	MGI:2156005	Hpi2<C57BL/6J>	MGI:2156005	Hpi2<C57BL/6J>	involves: A/J # C57BL/6J	immune system: other functional anomaly	69153	TAS	PMN infiltration
MGI:1890481	Igfbp3q1	MGI:2156008	Igfbp3q1<DU6i>	MGI:2156008	Igfbp3q1<DU6i>	involves: DBA/2J # DU6i	no obvious phenotype: no defect detected	68837	TAS	serum protein level
MGI:1890481	Igfbp3q1	MGI:2156008	Igfbp3q1<DU6i>	MGI:2156009	Igfbp3q1<DBA/2>	involves: DBA/2J # DU6i	no obvious phenotype: no defect detected	68837	TAS	serum protein level
MGI:105961	Lbw3	MGI:2156283	Lbw3<NZW/LacScr>	MGI:2156283	Lbw3<NZW/LacScr>	involves: NZB/BlScr # NZW/LacScr	immune system: hypersensitivity	20991	TAS	SLE susceptibility
MGI:2150908	Listr1	MGI:2156006	Listr1<BALB/cByJ>	?	?	involves: BALB/cByJ # C57BL/6ByJ	immune system: other functional anomaly	68879	TAS	listeriosis resistance
MGI:1203737	Lmb2	?	?	?	?	involves: C57BL/6-Tnfrsf6<lpr> # MRL-Tnfrsf6<lpr>	immune system: hypersensitivity	45708	TAS	lymphadenopathy
MGI:1203737	Lmb2	?	?	?	?	involves: C57BL/6-Tnfrsf6<lpr> # MRL-Tnfrsf6<lpr>	immune system: hypersensitivity	45708	TAS	splenomegaly
MGI:1203737	Lmb2	?	?	?	?	involves: C57BL/6-Tnfrsf6<lpr> # MRL-Tnfrsf6<lpr>	immune system: hypersensitivity	45708	TAS	anti-dsDNA antibody production
MGI:2149006	Lprm4	MGI:2156224	Lprm4<MRL/MpJ>	MGI:2156224	Lprm4<MRL/MpJ>	involves: C3H/HeJ-Tnfrsf6<lpr>/Tnfrsf6<lpr> # MRL/MpJ-Tnfrsf6<lpr>/Tnfrsf6<lpr>	immune system: hypersensitivity	44625	TAS	splenomegaly
MGI:1316704	Lwq2	?	?	?	?	involves: DU6 # DUKs	liver/hepatic system: dysmorphology	49578	TAS	liver weight
MGI:1316704	Lwq2	?	?	?	?	involves: DBA/2J # DU6i	liver/hepatic system: dysmorphology	66233	TAS	liver weight
MGI:2148813	Manh6	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	67526	TAS	mandible morphology
MGI:2148844	Many3	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	67526	TAS	mandible morphology
MGI:1930242	Nob1	MGI:2156037	Nob1<NZO/HlBom>	?	?	involves: NZO/HlBom # SJL/NBom 	growth/weight abnormality: postnatal	66744	TAS	adiposity
MGI:1930242	Nob1	MGI:2156037	Nob1<NZO/HlBom>	?	?	involves: NZO/HlBom # SJL/NBom 	metabolism: abnormal glucose homeostasis	66744	TAS	insulin resistance
MGI:2150700	Obq11	MGI:2156025	Obq11<NZO/HlLt>	?	?	involves: NZO/HILt # SM/J	growth/weight abnormality: postnatal	67838	TAS	adiposity
MGI:2150701	Obq12	MGI:2156027	Obq12<NZO/HlLt>	?	?	involves: NZO/HILt # SM/J	growth/weight abnormality: postnatal	67838	TAS	adiposity
MGI:2149337	Pgia16	MGI:2156060	Pgia16<C3H/HeJCr>	MGI:2156060	Pgia16<C3H/HeJCr>	involves: C3H/HeJCr # C57BL/6	immune system: hypersensitivity	65424	TAS	arthritis
MGI:104791	Skts3	?	?	?	?	involves: NIH/Ola # M. spretus	tumors: increased incidence	27733	TAS	skin tumor susceptibility
MGI:1277159	Skts4	MGI:2156219	Skts4<SENCARA/Pt>	?	?	involves: BALB/cAnPt # SENCARA/Pt	tumors: increased incidence	48305	TAS	skin tumor susceptibility
MGI:1353465	Sle6	MGI:2156085	Sle6<NZW>	MGI:2156085	Sle6<NZW>	involves: C57BL/6 # NZW	immune system: hypersensitivity	57246	TAS	SLE susceptibility
MGI:2148673	Szs11	MGI:2155998	Szs11<DBA/2J>	MGI:2155998	Szs11<DBA/2J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: seizures/epilepsy	70295	TAS	seizure susceptibility
MGI:2148673	Szs11	MGI:2155998	Szs11<DBA/2J>	MGI:2155997	Szs11<C57BL/6J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: seizures/epilepsy	70295	TAS	seizure susceptibility
MGI:1345672	Szs6	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: seizures/epilepsy	56630	TAS	seizure susceptibility
MGI:1098562	Szv1	MGI:2156229	Szv1<C57BL/6J>	MGI:2156229	Szv1<C57BL/6J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: seizures/epilepsy	38888	TAS	seizure severity
MGI:2149042	Adip2	MGI:2156452	Adip2<LG/J>	MGI:2156452	Adip2<LG/J>	involves: LG/J # SM/J	growth/weight abnormality: postnatal	62610	TAS	adiposity
MGI:2149042	Adip2	MGI:2156452	Adip2<LG/J>	MGI:2156453	Adip2<SM/J>	involves: LG/J # SM/J	growth/weight abnormality: postnatal	62610	TAS	adiposity
MGI:2149042	Adip2	MGI:2156453	Adip2<SM/J>	MGI:2156453	Adip2<SM/J>	involves: LG/J # SM/J	growth/weight abnormality: postnatal	62610	TAS	adiposity
MGI:2151624	Artles	MGI:2153860	Artles<C57BL/6J>	MGI:2156399	Artles<CAST/Ei>	involves: C57BL/6J # CAST/Ei	metabolism: abnormal glucose homeostasis	70961	TAS	plasma insulin level
MGI:2151624	Artles	MGI:2153860	Artles<C57BL/6J>	MGI:2156399	Artles<CAST/Ei>	involves: C57BL/6J # CAST/Ei	heart/cardiovascular system: other functional anomalies	70961	TAS	arterial lesions
MGI:1933989	Athsq2	MGI:2156388	Athsq2<C57BL/6J>	MGI:2156388	Athsq2<C57BL/6J>	involves: B6.129S7-Ldlr<tm1Her> # C57BL/6J-Ldlr<tm1Her> # MOLF/Ei	heart/cardiovascular system: other functional anomalies	70259	TAS	atherosclerosis susceptibility
MGI:2149354	Bbaa5	?	?	?	?	involves: C3H/HeNCr # C57BL/6NCr	immune system: no defect detected	52017	TAS	IgM production
MGI:2149354	Bbaa5	?	?	?	?	involves: C3H/HeNCr # C57BL/6NCr	immune system: no defect detected	52017	TAS	B.burgdorferi-specific IgM production
MGI:2151121	Bdt3	?	?	?	?	involves: C57BL/6J # DBA/2J	skeletal: osteogenesis/developmental anomalies	69682	TAS	bone density
MGI:108547	Bgeq4	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	32208	TAS	growth rate
MGI:108547	Bgeq4	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	60662	TAS	growth rate
MGI:108546	Bglq5	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	32208	TAS	growth rate
MGI:108546	Bglq5	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	60662	TAS	growth rate
MGI:1351272	Bhr5	?	?	?	?	involves: A/J # C3H/HeJ	immune system: hypersensitivity	59047	TAS	airway hyperresponsiveness
MGI:1351272	Bhr5	MGI:2156474	Bhr5<A/J>	?	?	involves: A/J # C3H/HeJ	immune system: hypersensitivity	33778	TAS	airway hyperresponsiveness
MGI:2150764	Bits2	MGI:2156410	Bits2<NZB/BlNJ>	MGI:2156409	Bits2<C57BL/6By>	involves: C57BL/6By # NZB/BlNJ  	neurological/behavioral: feeding/drinking preference anomalies	68419	TAS	bitterness sensitivity
MGI:1891317	Bpq5	?	?	?	?	involves: A/J # C57BL/6J	heart/cardiovascular system: blood pressure anomalies	66987	TAS	blood pressure
MGI:1934674	Bts2	MGI:2156537	Bts2<NON/Shi>	?	?	involves: C57BL/6JShi # NON/Shi	tumors: increased incidence	51984	TAS	bladder tumor susceptibility
MGI:2151807	Bulb2	MGI:2156397	Bulb2<C57BL/6J>	?	?	involves: C57BL/6J # DBA/2J	central nervous system: other dysmorphology	71082	TAS	olfactory bulb size
MGI:1932503	Bw18	?	?	?	?	involves: A/J # SM/J	growth/weight abnormality: postnatal	64138	TAS	body weight
MGI:1298233	Bwq2	MGI:2156592	Bwq2<KK>	?	?	involves: C57BL/6J # KK-A<y>	growth/weight abnormality: postnatal	48704	TAS	body weight
MGI:1298233	Bwq2	MGI:2156592	Bwq2<KK>	?	?	involves: C57BL/6J # KK-A<y>	growth/weight abnormality: postnatal	48704	TAS	adiposity
MGI:1891195	Bwtq3	?	?	?	?	involves: C57BL/6J # DBA/2J	growth/weight abnormality: postnatal	53812	TAS	body weight
MGI:1858180	Cadfar	MGI:2156461	Cadfar<C57BL/6NCrlBr>	MGI:2156461	Cadfar<C57BL/6NCrlBr>	involves: C57BL/6NCrlBr # SWV/Fnn	growth/weight abnormality: embryonic	60691	TAS	forelimb malformation
MGI:99483	Chol2	?	?	?	?	involves: C57BL/6J # M. spretus	metabolism: abnormal lipid homeostasis	14189	TAS	plasma total cholesterol level
MGI:1333814	Cia3	?	?	?	?	involves: DBA/1J # SWR/J	immune system: hypersensitivity	53356	TAS	arthritis susceptibility
MGI:1345671	Cia6	MGI:2156516	Cia6<C57BL/10>	MGI:2156516	Cia6<C57BL/10>	involves: B10.Q # DBA/1	immune system: hypersensitivity	57012	TAS	arthritis onset
MGI:1345671	Cia6	MGI:2156516	Cia6<C57BL/10>	MGI:2156517	Cia6<DBA/1J>	involves: B10.Q # DBA/1	immune system: hypersensitivity	57012	TAS	arthritis onset
MGI:1346026	Cms2	MGI:2156519	Cms2<DBA/2J>	?	?	involves: C57BL/6J # DBA/2J	immune system: other functional anomaly	55132	TAS	infection resistance
MGI:2150995	Cocrb7	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	68421	TAS	repeated movements
MGI:2137483	Etlm3	?	?	?	?	involves: BALB/cJ # LP/J	neurological/behavioral: no defect detected	68417	TAS	locomotor activity
MGI:2148660	Etohcta6	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	50271	TAS	conditioned taste aversion
MGI:2149370	Fglu	MGI:2156633	Fglu<KK/Jcl>	MGI:2156633	Fglu<KK/Jcl>	involves: C57BL/6Jcl # KK.B6-A<y>/Jcl	metabolism: abnormal glucose homeostasis	51880	TAS	plasma glucose level
MGI:1861748	Ichs	MGI:2156447	Ichs<C57BL/6J>	MGI:2156447	Ichs<C57BL/6J>	involves: A/J # C57BL/6J # C57BL/6JOlaHsd	immune system: hypersensitivity	63737	TAS	cutaneous hypersensitivity
MGI:1861748	Ichs	MGI:2156448	Ichs<C57BL/6JOlaHsd>	MGI:2156448	Ichs<C57BL/6JOlaHsd>	involves: A/J # C57BL/6J # C57BL/6JOlaHsd	immune system: hypersensitivity	63737	TAS	cutaneous hypersensitivity
MGI:2151061	Idd20	MGI:2156392	Idd20<C3H/HeJ>	MGI:2156392	Idd20<C3H/HeJ>	involves: C3H/HeJ # NOD/Lt	metabolism: abnormal glucose homeostasis	69992	TAS	diabetes susceptibility
MGI:2152339	Ifnm	MGI:2156401	Ifnm<C57BL/10ScCr>	MGI:2156401	Ifnm<C57BL/10ScCr>	involves: 129S2/SvPas # C57BL/10ScCr	immune system: other functional anomaly	70821	TAS	antibody response
MGI:2148495	Insq8	MGI:2156457	Insq8<C57BL/6>	?	?	involves: 129S2/SvPas # C57BL/6	metabolism: abnormal glucose homeostasis	61489	TAS	plasma insulin level
MGI:105960	Lbw4	?	?	?	?	involves: C57BL/6J # NZM2410/Aeg 	immune system: hypersensitivity	52863	TAS	anti-MPO production
MGI:105960	Lbw4	?	?	?	?	involves: C57BL/6J # NZM2410/Aeg 	immune system: hypersensitivity	52863	TAS	anti-dsDNA production
MGI:2148814	Manh7	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	67526	TAS	mandible morphology
MGI:2148815	Manh8	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	67526	TAS	mandible morphology
MGI:2148835	Manz4	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	67526	TAS	mandible size
MGI:99506	Mob2	?	?	?	?	involves: C57BL/6J # M. spretus	growth/weight abnormality: postnatal	14189	TAS	adiposity
MGI:99507	Mop1	MGI:2156652	Mop1<C57BL/6J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	17972	TAS	morphine consumption
MGI:1355301	Nidd3n	?	?	?	?	involves: C3H/HeCrj # NSY	growth/weight abnormality: postnatal	55284	TAS	adiposity
MGI:1355301	Nidd3n	?	?	?	?	involves: C3H/HeCrj # NSY	growth/weight abnormality: postnatal	55284	TAS	plasma insulin levels
MGI:2150702	Obq13	MGI:2156430	Obq13<NZO/HlLt>	?	?	involves: NZO/HILt # SM/J	growth/weight abnormality: postnatal	67838	TAS	adiposity
MGI:2150703	Obq14	MGI:2156432	Obq14<NZO/HlLt>	?	?	involves: NZO/HILt # SM/J	growth/weight abnormality: postnatal	67838	TAS	adiposity
MGI:1196401	Oriq3	?	?	?	?	involves: A/J # C57BL/6J 	reproductive system: no defect detected	44129	TAS	ovulation rate
MGI:109357	Ots1	MGI:2156627	Ots1<LT/Sv>	MGI:2156627	Ots1<LT/Sv>	involves: C57BL/6J # LT/Sv	tumors: increased incidence	38481	TAS	ovarian tumor susceptibility
MGI:109357	Ots1	MGI:2156627	Ots1<LT/Sv>	MGI:2156628	Ots1<C57BL/6J>	involves: C57BL/6J # LT/Sv	tumors: increased incidence	38481	TAS	ovarian tumor susceptibility
MGI:2137387	Pabr1	?	?	?	?	involves: 129X1/SvJ # B6HuBTg 	metabolism: abnormal lipid homeostasis	69759	TAS	plasma apoB level
MGI:2137387	Pabr1	?	?	?	?	involves: 129X1/SvJ # B6HuBTg 	metabolism: abnormal lipid homeostasis	69759	TAS	plasma apoB level
MGI:2137387	Pabr1	?	?	?	?	involves: 129X1/SvJ # B6HuBTg 	metabolism: abnormal lipid homeostasis	69759	TAS	plasma apoB level
MGI:1197520	Par4	MGI:2156625	Par4<BALB/cJ>	MGI:2156625	Par4<BALB/cJ>	involves: BALB/cJ # SWR/J	tumors: no increased incidence	43176	TAS	lung tumor resistance
MGI:1197520	Par4	MGI:2156625	Par4<BALB/cJ>	MGI:2156626	Par4<SWR/J>	involves: BALB/cJ # SWR/J	tumors: no increased incidence	43176	TAS	lung tumor resistance
MGI:97481	Pas1	?	?	?	?	involves: A/J # C3H/He	tumors: increased incidence	3876	TAS	lung tumor susceptibility
MGI:97481	Pas1	?	?	?	?	involves: A/J # C57BL/6J	tumors: increased incidence	48996	TAS	lung tumor susceptibility
MGI:97481	Pas1	MGI:2156573	Pas1<A/J>	?	?	involves: A/J # C57BL/6JBy # M. spretus	tumors: increased incidence	29218	TAS	lung tumor susceptibility
MGI:1345294	Pas1c	MGI:2156544	Pas1c<BALB/cOlaHsd>	?	?	involves: A/JOlaHsd # BALB/cOlaHsd	tumors: increased incidence	50533	TAS	lung tumor susceptibility
MGI:2150194	Rencd	MGI:2156439	Rencd<CAST/Ei>	MGI:2156439	Rencd<CAST/Ei>	involves: BALB/c-+/bpk # CAST/Ei	kidney/renal system: functional anomalies	66475	TAS	renal cystic disease severity
MGI:2151137	Rhs1	MGI:2156406	Rhs1<C57BL/6>	MGI:2156406	Rhs1<C57BL/6>	involves: BALB/c # C57BL/6	immune system: other functional anomaly	69352	TAS	herpes resistance
MGI:2151137	Rhs1	MGI:2156405	Rhs1<BALB/c>	?	?	involves: BALB/c # C57BL/6	immune system: other functional anomaly	69352	TAS	herpes susceptiblity
MGI:2149052	Skl3	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	62610	TAS	skeletal length
MGI:1351483	Skts11	MGI:2156467	Skts11<M. spretus>	MGI:2156467	Skts11<M. spretus>	involves: M. spretus # NIH/Ola	tumors: increased incidence	59049	TAS	skin tumor susceptibility
MGI:1351470	Skts12	MGI:2156470	Skts12<M. spretus>	MGI:2156470	Skts12<M. spretus>	involves: M. spretus # NIH/Ola	tumors: increased incidence	59049	TAS	skin tumor susceptibility
MGI:1351470	Skts12	MGI:2156470	Skts12<M. spretus>	MGI:2156471	Skts12<NIH/Ola>	involves: M. spretus # NIH/Ola	tumors: increased incidence	59049	TAS	skin tumor susceptibility
MGI:2149688	Skull7	MGI:2156522	Skull7<LG/J>	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	53484	TAS	skull morphology
MGI:2149689	Skull8	MGI:2156524	Skull8<LG/J>	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	53484	TAS	skull morphology
MGI:2155622	Sluc3	?	?	?	?	involves: B10.O20/Dem # O20/A	tumors: increased incidence	36997	TAS	lung tumor susceptibility
MGI:1335097	Sluc7	?	?	?	?	involves: B10.O20/Dem # O20/A	tumors: increased incidence	50525	TAS	lung tumor susceptibility
MGI:2148667	Taste5	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	50271	TAS	saccharin preference
MGI:2148966	Taste8	?	?	?	?	involves: C3H/HeJ # C57BL/6J	neurological/behavioral: feeding/drinking preference anomalies	48606	TAS	bitterness sensitivity
MGI:2148967	Taste9	?	?	?	?	involves: C3H/HeJ # C57BL/6J	neurological/behavioral: feeding/drinking preference anomalies	48606	TAS	bitterness sensitivity
MGI:1927661	Trbv4c2	?	?	?	?	involves: C57BL/6J # DBA/2J	immune system: lymphoid development/ T lymphocyte defects	71668	TAS	lymphocyte proliferation
MGI:1927661	Trbv4c2	?	?	?	?	involves: C57BL/6J # DBA/2J	immune system: lymphoid development/ T lymphocyte defects	71668	TAS	lymphocyte proliferation
MGI:2149060	Wta2	MGI:2156450	Wta2<LG/J>	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	62610	TAS	body weight
MGI:2148588	Abhr3	?	?	?	?	involves: A/J # C3H/HeJ 	immune system: hypersensitivity	66641	TAS	airway hyperresponsiveness
MGI:2149043	Adip3	MGI:2156714	Adip3<LG/J>	MGI:2156714	Adip3<LG/J>	involves: LG/J # SM/J	growth/weight abnormality: postnatal	62610	TAS	body weight
MGI:2149043	Adip3	MGI:2156714	Adip3<LG/J>	MGI:2156715	Adip3<SM/J>	involves: LG/J # SM/J	growth/weight abnormality: postnatal	62610	TAS	body weight
MGI:2137852	Aem2	MGI:2156720	Aem2<C57BL/6>	MGI:2156720	Aem2<C57BL/6>	involves: C57BL/6 # NZB	immune system: no defect detected	59427	TAS	autoantibody production
MGI:2137852	Aem2	MGI:2156720	Aem2<C57BL/6>	MGI:2156721	Aem2<NZB>	involves: C57BL/6 # NZB	immune system: no defect detected	59427	TAS	autoantibody production
MGI:1889213	Afpq9	MGI:2156702	Afpq9<DU6i>	?	?	involves: DBA/2J # DU6i	growth/weight abnormality: postnatal	66233	TAS	adiposity
MGI:1890482	Afw9	MGI:2156705	Afw9<DU6i>	?	?	involves: DBA/2J # DU6i	growth/weight abnormality: postnatal	66233	TAS	adiposity
MGI:1858390	Alcp11	?	?	?	?	involves: A/J # C57BL/6J	neurological/behavioral: feeding/drinking preference anomalies	52467	TAS	alcohol preference
MGI:1858391	Alcp12	?	?	?	?	involves: A/J # C57BL/6J	neurological/behavioral: feeding/drinking preference anomalies	52467	TAS	alcohol preference
MGI:1858392	Alcp13	?	?	?	?	involves: A/J # C57BL/6J	neurological/behavioral: feeding/drinking preference anomalies	52467	TAS	alcohol preference
MGI:1858393	Alcp14	?	?	?	?	involves: A/J # C57BL/6J	neurological/behavioral: feeding/drinking preference anomalies	52467	TAS	alcohol preference
MGI:2151079	Angle4	?	?	?	?	involves: BALB/cJ # C57BL/6J	neurological/behavioral: sleep pattern/circadian rhythm anomalies	69972	TAS	angle of entrainment
MGI:2148546	Axtofa3	?	?	?	?	(H1 x L1)F2	neurological/behavioral: fear/anxiety	70479	TAS	open field activity
MGI:2148546	Axtofa3	?	?	?	?	(H2 x L2)F2	neurological/behavioral: fear/anxiety	70479	TAS	open field activity
MGI:2148556	Axtofd2	?	?	?	?	(H1 x L1)F2	neurological/behavioral: fear/anxiety	70479	TAS	open field defecation
MGI:2148556	Axtofd2	?	?	?	?	(H2 x L2)F2	neurological/behavioral: fear/anxiety	70479	TAS	open field defecation
MGI:2148562	Axtrb1	?	?	?	?	(H1 x L1)F2	neurological/behavioral: fear/anxiety	70479	TAS	open field defecation
MGI:2148562	Axtrb1	?	?	?	?	(H2 x L2)F2	neurological/behavioral: fear/anxiety	69668	TAS	anxiety related behavior
MGI:2151122	Bdt4	?	?	?	?	involves: C57BL/6J # DBA/2J	skeletal: osteogenesis/developmental anomalies	69682	TAS	bone density
MGI:108542	Bgeq5	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	32208	TAS	growth rate
MGI:108542	Bgeq5	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	60662	TAS	growth rate
MGI:108541	Bgeq6	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	32208	TAS	growth rate
MGI:108540	Bglq6	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	32208	TAS	growth rate
MGI:108540	Bglq6	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	60662	TAS	growth rate
MGI:2150651	Bhr6	?	?	?	?	involves: A/J # C3H/HeJ	immune system: hypersensitivity	59047	TAS	airway hyperresponsiveness
MGI:1343055	Bis4	MGI:2156751	Bis4<A/J>	?	?	involves: A/J # C57BL/6J 	neurological/behavioral: seizures/epilepsy	54925	TAS	seizure susceptibility
MGI:2149339	Bomd1	?	?	?	?	involves: C57BL/6J # DBA/2J	skeletal: osteogenesis/developmental anomalies	50828	TAS	bone density
MGI:1889215	Bw14	MGI:2156707	Bw14<DU6i>	?	?	involves: DBA/2J # DU6i	growth/weight abnormality: postnatal	66233	TAS	body weight
MGI:99482	Chol1	?	?	?	?	involves: C57BL/6J # M. spretus	metabolism: abnormal lipid homeostasis	14189	TAS	plasma cholesterol level
MGI:1345670	Cia7	MGI:2156731	Cia7<DBA/1J>	MGI:2156731	Cia7<DBA/1J>	involves: B10.Q # DBA/1	immune system: hypersensitivity	57012	TAS	arthritis severity
MGI:1345670	Cia7	MGI:2156731	Cia7<DBA/1J>	MGI:2156732	Cia7<C57BL/10>	involves: B10.Q # DBA/1	immune system: hypersensitivity	57012	TAS	arthritis severity
MGI:2148652	Cons2	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	50271	TAS	saccharin consumption
MGI:2150996	Dautb2	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	68421	TAS	dopamine uptake transporter binding
MGI:2149368	Dice2	?	?	?	?	involves: BALB/c # C57BL/6 	immune system: no defect detected	51707	TAS	IL-4 level
MGI:892987	Dyscalc1	?	?	?	?	involves: C57BL/6Ola # DBA/2Ola	kidney/renal system: dysmorphology	51569	TAS	soft tissue calcification
MGI:892987	Dyscalc1	?	?	?	?	involves: C57BL/6Ola # DBA/2Ola	heart/cardiovascular system: dysmorphology	51569	TAS	soft tissue calcification
MGI:892987	Dyscalc1	?	?	?	?	involves: C57BL/6Ola # DBA/2Ola	other aberrant phenotype	51569	TAS	soft tissue calcification
MGI:892987	Dyscalc1	MGI:2156660	Dyscalc1<C3H/HeJ>	MGI:2156660	Dyscalc1<C3H/HeJ>	involves: C3H/HeJ # C57BL/6J	heart/cardiovascular system: dysmorphology	72021	TAS	cardiac calcinosis
MGI:892987	Dyscalc1	MGI:2156660	Dyscalc1<C3H/HeJ>	MGI:2156660	Dyscalc1<C3H/HeJ>	involves: C3H/HeJ # C57BL/6J	heart/cardiovascular system: dysmorphology	33253	TAS	cardiac calcinosis
MGI:892987	Dyscalc1	MGI:2156733	Dyscalc1<DBA/2J>	MGI:2156733	Dyscalc1<DBA/2J>	involves: C57BL/6J # DBA/2J	heart/cardiovascular system: dysmorphology	56263	TAS	cardiac calcinosis
MGI:1339947	Eae12	MGI:2156761	Eae12<SJL/J>	MGI:2156761	Eae12<SJL/J>	involves: B10.S/DvTe # SJL/J	immune system: hypersensitivity	53193	TAS	EAE remitting/relapsing susceptibility
MGI:1309483	Eae4	MGI:2156869	Eae4<ABH>	?	?	involves: ABH # NOD	immune system: hypersensitivity	29171	TAS	EAE susceptibility
MGI:1309483	Eae4	MGI:2156762	Eae4<B10.S/DvTe>	MGI:2156762	Eae4<B10.S/DvTe>	involves: B10.S/DvTe # SJL/J	immune system: hypersensitivity	49054	TAS	EAE susceptibility
MGI:1309483	Eae4	MGI:2156762	Eae4<B10.S/DvTe>	?	?	involves: B10.S/DvTe # SJL/J	immune system: hypersensitivity	53193	TAS	EAE remitting/relapsing susceptibility
MGI:2148661	Etohcta7	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	50271	TAS	conditioned taste aversion
MGI:1098218	Faq3	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	42413	TAS	mandible morphology
MGI:96056	Hcs1	MGI:2156892	Hcs1<C3H/He>	?	?	involves: A/J # C3H/He	tumors: increased incidence	3657	TAS	liver tumor susceptibility
MGI:2148578	Heal6	MGI:2156806	Heal6<MRL/MpJ>	?	?	involves: C57BL/6Tac # MRL/MpJ-Tnfrsf6<lpr>	skin: no defect detected	50111	TAS	healing/regeneration
MGI:1344356	Hlq5	MGI:2156747	Hlq5<MH>	?	?	involves: C57BL/6J # MH	metabolism: no defect detected	55483	TAS	heat loss
MGI:1889221	Kwq7	?	?	?	?	involves: DBA/2J # DU6i	kidney/renal system: dysmorphology	66233	TAS	kidney weight
MGI:105957	Lbw5	MGI:2156880	Lbw5<NZW/LacScr>	MGI:2156880	Lbw5<NZW/LacScr>	involves: NZB/BlScr # NZW/LacScr	immune system: hypersensitivity	20991	TAS	SLE susceptibility
MGI:105957	Lbw5	MGI:2156880	Lbw5<NZW/LacScr>	MGI:2156879	Lbw5<NZB/BlScr>	involves: NZB/BlScr # NZW/LacScr	immune system: hypersensitivity	20991	TAS	SLE susceptibility
MGI:105957	Lbw5	?	?	?	?	involves: C57BL/6 # NZM2410	immune system: hypersensitivity	52863	TAS	glomerulonephritis
MGI:1344422	Livq1	MGI:2156749	Livq1<MH>	?	?	involves: C57BL/6J # MH	liver/hepatic system: dysmorphology	55483	TAS	liver weight
MGI:1203736	Lmb3	MGI:2156814	Lmb3<MRL>	?	?	involves: C57BL/6-Tnfrsf6<lpr> # MRL-Tnfrsf6<lpr>	immune system: hypersensitivity	45708	TAS	lymphadenopathy
MGI:1203736	Lmb3	MGI:2156814	Lmb3<MRL>	?	?	involves: C57BL/6-Tnfrsf6<lpr> # MRL-Tnfrsf6<lpr>	immune system: hypersensitivity	45708	TAS	splenomegaly
MGI:1096563	Lore7	?	?	?	?	involves: LS # SS	neurological/behavioral: no defect detected	38534	TAS	sleep time
MGI:1203483	Lorp1	MGI:2156810	Lorp1<LS>	MGI:2156811	Lorp1<SS>	involves: LS # SS	neurological/behavioral: no defect detected	46300	TAS	sleep time
MGI:106097	Lrdm1	?	?	?	?	involves: CAST/Ei # MRL/MpJ-Tnfrsf6<lpr>	immune system: lymphoid development/ T lymphocyte defects	3304	TAS	lymphocyte proliferation
MGI:106097	Lrdm1	?	?	?	?	involves: C57BL/6 # NZM2410	immune system: lymphoid development/ T lymphocyte defects	52863	TAS	anti-dsDNA antibody production
MGI:1889223	Lwq6	?	?	?	?	involves: DBA/2J # DU6i	liver/hepatic system: dysmorphology	66233	TAS	liver weight
MGI:2148817	Manh10	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	67526	TAS	mandible morphology
MGI:2148816	Manh9	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	67526	TAS	mandible morphology
MGI:2148836	Manz5	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	67526	TAS	mandible size
MGI:1306807	Mlviq1	?	?	?	?	involves: BALB/cBy # C57BL/6By	immune system: other functional anomaly	43753	TAS	immune response
MGI:1890552	Mmtg3	?	?	?	?	involves: FVB/NJ # FVB/NMul-TgN(MMTVPyVT)<634mul> # I/LnJ	tumors: increased incidence	70229	TAS	mammary tumor growth
MGI:99505	Mob1	?	?	?	?	involves: C57BL/6J # M. spretus	metabolism: abnormal lipid homeostasis	14189	TAS	plasma cholesterol level
MGI:99505	Mob1	?	?	?	?	involves: C57BL/6J # M. spretus	growth/weight abnormality: postnatal	14189	TAS	body weight
MGI:99505	Mob1	?	?	?	?	involves: C57BL/6J # M. spretus	other aberrant phenotype	14189	TAS	percent body water
MGI:99505	Mob1	?	?	?	?	involves: C57BL/6J # M. spretus	growth/weight abnormality: postnatal	14189	TAS	adiposity
MGI:1353475	Mol1	MGI:2156744	Mol1<BALB/cByJ>	MGI:2156744	Mol1<BALB/cByJ>	involves: BALB/cByJ # C57BL/6ByJ	immune system: other functional anomaly	58921	TAS	LPS response
MGI:1353475	Mol1	?	?	?	?	involves: A/J # C57BL/6J	immune system: other functional anomaly	58921	TAS	LPS response
MGI:1889226	Mwq1	?	?	?	?	involves: DBA/2J # DU6i	musculature: no defect detected	66233	TAS	quadriceps weight
MGI:109204	Obq1	MGI:2156845	Obq1<EL/Suz>	?	?	involves: 129T2/SvEmsJ # EL/SuZ	growth/weight abnormality: postnatal	33858	TAS	adiposity
MGI:2150704	Obq15	MGI:2156688	Obq15<NZO/HlLt>	MGI:2156688	Obq15<NZO/HlLt>	involves: NZO/HILt # SM/J	growth/weight abnormality: postnatal	67838	TAS	adiposity
MGI:2150704	Obq15	MGI:2156688	Obq15<NZO/HlLt>	MGI:2156689	Obq15<SM/J>	involves: NZO/HILt # SM/J	growth/weight abnormality: postnatal	67838	TAS	adiposity
MGI:2151211	Pgia3	MGI:2156701	Pgia3<DBA/2Crl>	?	?	involves: BALB/cCrl # DBA/2Crl	immune system: hypersensitivity	66460	TAS	autoantibody production
MGI:2151211	Pgia3	MGI:2156700	Pgia3<BALB/cCrl>	?	?	involves: BALB/cCrl # DBA/2Crl	immune system: hypersensitivity	66460	TAS	inflammation
MGI:1330298	Rigs1	MGI:2156784	Rigs1<HLG>	MGI:2156784	Rigs1<HLG>	involves: C57BL/6J # HLG	digestive system: dysmorphology	52090	TAS	gastroschisis
MGI:2149827	Scpro1	?	?	?	?	involves: C57BL/6J # DBA/2J	other aberrant phenotype	54115	TAS	stem cell proliferation
MGI:104788	Skts1	MGI:2156686	Skts1<Car-S>	MGI:2156686	Skts1<Car-S>	involves: Car-R # Car-S	tumors: increased incidence	68404	TAS	skin tumor susceptibility
MGI:104788	Skts1	MGI:2156872	Skts1<NIH/Ola>	?	?	involves: NIH # M. spretus	tumors: increased incidence	27733	TAS	skin tumor susceptibility
MGI:104787	Skts2	MGI:2156874	Skts2<NIH/Ola>	?	?	involves: NIH # M. spretus	tumors: increased incidence	27733	TAS	skin tumor susceptibility
MGI:2149692	Skull10	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	53484	TAS	skull morphology
MGI:2149690	Skull9	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	53484	TAS	skull morphology
MGI:105955	Sle3	?	?	?	?	involves: C57BL/6 # NZM2410	immune system: hypersensitivity	52863	TAS	glomerulonephritis
MGI:105955	Sle3	?	?	?	?	involves: C57BL/6 # NZM2410	immune system: hypersensitivity	52863	TAS	anti-ssDNA antibody production
MGI:105955	Sle3	?	?	?	?	involves: C57BL/6 # NZM2410	immune system: hypersensitivity	52863	TAS	anti-nuclear antibody production
MGI:105955	Sle3	?	?	?	?	involves: C57BL/6 # NZM2410	immune system: hypersensitivity	52863	TAS	anti-thryoglobulin production
MGI:105955	Sle3	MGI:2156753	Sle3<NZM2410/Aeg>	?	?	involves: C57BL/6 # NZM2410/Aeg	immune system: hypersensitivity	55031	TAS	splenomegaly
MGI:105955	Sle3	MGI:2156753	Sle3<NZM2410/Aeg>	?	?	involves: C57BL/6 # NZM2410/Aeg	immune system: hypersensitivity	55031	TAS	lymphocyte proliferation
MGI:1100862	Sle4	?	?	?	?	involves: C57BL/6J # DBA/2J	immune system: hypersensitivity	43152	TAS	SLE susceptibility
MGI:1335081	Sluc8	?	?	?	?	involves: B10.O20/Dem # O20/A	tumors: increased incidence	50525	TAS	lung tumor susceptibility
MGI:1098565	Szv2	MGI:2156837	Szv2<C57BL/6J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: seizures/epilepsy	38888	TAS	seizure severity
MGI:1932202	Tabw	MGI:2156676	Tabw<TH>	MGI:2156676	Tabw<TH>	involves: C57BL/6J # TH	growth/weight abnormality: postnatal	70227	TAS	body weight
MGI:1932202	Tabw	MGI:2156676	Tabw<TH>	MGI:2156676	Tabw<TH>	involves: CAST/Ei # TH	growth/weight abnormality: postnatal	70227	TAS	body weight
MGI:2150673	Tbrs3	MGI:2156690	Tbrs3<C57BL/6J>	?	?	involves: C57BL/6J # DBA/2J	immune system: other functional anomaly	67658	TAS	tuberculosis resistance
MGI:105954	Tlsm1	MGI:2156875	Tlsm1<AKR/J>	?	?	involves: AKR/J # DBA/2J	tumors: increased incidence	21741	TAS	lymphoma susceptibility
MGI:105954	Tlsm1	MGI:2156830	Tlsm1<AKR/Ms>	MGI:2156830	Tlsm1<AKR/Ms>	involves: AKR/Ms # SL/Kh	tumors: increased incidence	21741	TAS	lymphoma susceptibility
MGI:105954	Tlsm1	MGI:2156830	Tlsm1<AKR/Ms>	MGI:2156831	Tlsm1<SL/Kh>	involves: AKR/Ms # SL/Kh	tumors: increased incidence	21741	TAS	lymphoma susceptibility
MGI:105954	Tlsm1	MGI:2156830	Tlsm1<AKR/Ms>	MGI:2156830	Tlsm1<AKR/Ms>	involves: AKR/Ms # SL/Kh	tumors: increased incidence	41197	TAS	lymphoma susceptibility
MGI:105954	Tlsm1	MGI:2156830	Tlsm1<AKR/Ms>	MGI:2156831	Tlsm1<SL/Kh>	involves: AKR/Ms # SL/Kh	tumors: increased incidence	41197	TAS	lymphoma susceptibility
MGI:1343127	Tria4	MGI:2156739	Tria4<BALB/cHeA>	?	?	involves: BALB/c # STS/A	immune system: other functional anomaly	56029	TAS	lymphocyte response
MGI:2149548	Yaail	MGI:2156782	Yaail<NZW/Ola>	?	?	involves: C57BL/6Ola # NZW/Ola 	immune system: hypersensitivity	52110	TAS	glomerulonephritis
MGI:2149548	Yaail	MGI:2156782	Yaail<NZW/Ola>	?	?	involves: C57BL/6Ola # NZW/Ola 	immune system: hypersensitivity	52110	TAS	anti-dsDNA antibody production
MGI:2149044	Adip4	MGI:2157025	Adip4<LG/J>	MGI:2157025	Adip4<LG/J>	involves: LG/J # SM/J	growth/weight abnormality: postnatal	62610	TAS	adiposity
MGI:2149044	Adip4	MGI:2157025	Adip4<LG/J>	?	?	involves: LG/J # SM/J	skeletal: osteogenesis/developmental anomalies	62610	TAS	tail length
MGI:2151080	Angle5	?	?	?	?	involves: BALB/cJ # C57BL/6J	neurological/behavioral: sleep pattern/circadian rhythm anomalies	69972	TAS	angle of entrainment
MGI:108516	Bgeq7	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	32208	TAS	growth rate
MGI:108516	Bgeq7	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	60662	TAS	growth rate
MGI:1890413	Bwq3	MGI:2156992	Bwq3<SM/J>	?	?	involves: A/J # SM/J	growth/weight abnormality: postnatal	71465	TAS	body weight
MGI:1891175	Cbm2	?	?	?	?	involves: C57BL/6J # DBA/2J	central nervous system: other dysmorphology	70179	TAS	cerebellum weight
MGI:1891175	Cbm2	?	?	?	?	involves: C57BL/6J # DBA/2J	central nervous system: other dysmorphology	70179	TAS	cerebellum morphology
MGI:1101773	Char2	?	?	?	?	involves: C3H/He # C57BL/6 	immune system: other functional anomaly	44414	TAS	malaria resistance
MGI:2148653	Cons3	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	50271	TAS	saccharin consumption
MGI:2149678	Daq19	?	?	?	?	involves: CAST/Ei # M16i	skeletal: craniofacial defects	64141	TAS	mandible morphology
MGI:1891336	Eae14	MGI:2157005	Eae14<B10.S/DvTe>	?	?	involves: B10.S/DvTe # SJL/J	immune system: hypersensitivity	69083	TAS	EAE susceptibility
MGI:1891336	Eae14	MGI:2157005	Eae14<B10.S/DvTe>	?	?	involves: B10.S/DvTe # SJL/J	immune system: hypersensitivity	69083	TAS	EAE severity
MGI:1891336	Eae14	MGI:2157005	Eae14<B10.S/DvTe>	?	?	involves: B10.S/DvTe # SJL/J	immune system: hypersensitivity	69083	TAS	spinal chord demyelination
MGI:2150664	Eae24	?	?	?	?	involves: B10.S # SJL/J	immune system: hypersensitivity	67793	TAS	inflammation
MGI:2150664	Eae24	?	?	?	?	involves: B10.S # SJL/J	immune system: hypersensitivity	67793	TAS	paralysis
MGI:96057	Hcs2	MGI:2157085	Hcs2<C3H/He>	?	?	involves: A/J # C3H/He	tumors: increased incidence	3657	TAS	liver tumor susceptibility
MGI:2148572	Heal1	MGI:2157054	Heal1<C57BL/6Tac>	?	?	involves: C57BL/6Tac # MRL/MpJ-Tnfrsf6<lpr>	skin: no defect detected	50111	TAS	healing/regeneration
MGI:2149994	Iba3	MGI:2157021	Iba3<A/J>	?	?	involves: A/J # C57BL/6J	metabolism: no defect detected	65478	TAS	weight loss
MGI:2148963	Im1	MGI:2157088	Im1<ABH>	?	?	involves: ABH # ABL	immune system: other functional anomaly	46394	TAS	antibody response
MGI:1096559	Lore3	?	?	?	?	involves: LS # SS	neurological/behavioral: no defect detected	38534	TAS	sleep time
MGI:1274788	Orch6	?	?	?	?	involves: B10.S/DvTe # SJL/J	immune system: hypersensitivity	47821	TAS	orchitis
MGI:2151212	Pgia4	MGI:2157012	Pgia4<BALB/cCrl>	?	?	involves: BALB/cCrl # DBA/2Crl	immune system: hypersensitivity	66460	TAS	autoantibody production
MGI:2151897	Pitm3	MGI:2156998	Pitm3<C57BL/FaDk>	MGI:2156998	Pitm3<C57BL/FaDk>	involves: C57BL/FaDk # RIII/FaDk	central nervous system: other functional anomalies	70033	TAS	prion incubation time
MGI:2151897	Pitm3	MGI:2156998	Pitm3<C57BL/FaDk>	MGI:2156999	Pitm3<RIII/FaDk>	involves: C57BL/FaDk # RIII/FaDk	central nervous system: other functional anomalies	70033	TAS	prion incubation time
MGI:2150657	Pvcan1	?	?	?	?	involves: BALB/cByJ # C57BL/6ByJ	immune system: other functional anomaly	57639	TAS	candidiasis resistance
MGI:1347109	Scc8	?	?	?	?	involves: BALB/cHeA # STS/A	tumors: increased incidence	57235	TAS	colon tumor susceptibility
MGI:1100538	Siafq1	MGI:2157074	Siafq1<DBA/2>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: sensory capabilities/reflexes/nociception abnormalities	43467	TAS	stress induced analgesia
MGI:1100538	Siafq1	MGI:2157074	Siafq1<DBA/2>	?	?	involves: C57BL/6 # DBA/2	neurological/behavioral: sensory capabilities/reflexes/nociception abnormalities	43467	TAS	stress induced analgesia
MGI:2149693	Skull11	MGI:2157039	Skull11<LG/J>	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	53484	TAS	skull morphology
MGI:1335080	Sluc9	?	?	?	?	involves: B10.O20/Dem # O20/A	tumors: increased incidence	50525	TAS	lung tumor susceptibility
MGI:2148968	Taste10	?	?	?	?	involves: C3H/HeJ # C57BL/6J	neurological/behavioral: feeding/drinking preference anomalies	48606	TAS	bitterness sensitivity
MGI:1933814	Wg3	MGI:2157007	Wg3<C57BL/6J>	?	?	involves: C57BL/6J-Cish2<hg>/Cish2<hg> # CAST/EiJ	growth/weight abnormality: postnatal	68441	TAS	growth rate
MGI:2150033	Actd4	MGI:2157191	Actd4<DBA/2J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: motor capabilities/coordination/movement anomalies	65696	TAS	locomotor activity
MGI:2149045	Adip5	MGI:2157327	Adip5<SM/J>	MGI:2157327	Adip5<SM/J>	involves: LG/J # SM/J	growth/weight abnormality: postnatal	62610	TAS	adiposity
MGI:1316667	Afw4	?	?	?	?	involves: DU6 # DUKs	growth/weight abnormality: postnatal	49578	TAS	adiposity
MGI:2152432	Ap5q	MGI:2157427	Ap5q<C57BL/6J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	49707	TAS	alcohol preference
MGI:1891293	Apmt2	MGI:2157319	Apmt2<I/LnJ>	?	?	involves: FVB/NJ # FVB/N-TgN(MMTVPyVT)634Mul # I/LnJ	tumors: increased incidence	64663	TAS	mammary tumor susceptibility
MGI:2149358	Bbaa9	MGI:2157405	Bbaa9<C57BL/6NCr>	MGI:2157405	Bbaa9<C57BL/6NCr>	involves: C3H/HeNCr # C57BL/6NCr	immune system: no defect detected	52017	TAS	IgG production
MGI:2149358	Bbaa9	MGI:2157405	Bbaa9<C57BL/6NCr>	MGI:2157404	Bbaa9<C3H/HeNCr>	involves: C3H/HeNCr # C57BL/6NCr	immune system: no defect detected	52017	TAS	IgG production
MGI:108512	Bglq7	MGI:2157510	Bglq7<LG/J>	MGI:2157510	Bglq7<LG/J>	involves: LG/J # SM/J	growth/weight abnormality: postnatal	32208	TAS	growth rate
MGI:108512	Bglq7	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	60662	TAS	growth rate
MGI:2137478	Bslm1	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: motor capabilities/coordination/movement anomalies	68417	TAS	locomotor activity
MGI:2150123	Bwtq4	?	?	?	?	involves: C57BL/6J # DBA/2J	growth/weight abnormality: postnatal	53812	TAS	body weight
MGI:2137239	C10bw2	MGI:2157244	C10bw2<M. m. castaneus>	?	?	involves: C57BL/6J # M. m. castaneus	growth/weight abnormality: postnatal	64750	TAS	body weight
MGI:2150829	Cafq3	?	?	?	?	involves: APN # C3H/HeJ	metabolism: no defect detected	68139	TAS	caffeine metabolism
MGI:1933826	Carf2	MGI:2157111	Carf2<CAST/EiJ>	?	?	involves: CAST/EiJ # C57BL/6J-Cish2<hg>/Cish2<hg>	growth/weight abnormality: postnatal	68441	TAS	percent carcass fat
MGI:1101772	Char1	?	?	?	?	involves: C3H/He # C57BL/6	immune system: other functional anomaly	44414	TAS	malaria resistance
MGI:2150999	Cocrb10	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	68421	TAS	exploratory behavior
MGI:2150997	Cocrb8	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	68421	TAS	repeated movements
MGI:2150998	Cocrb9	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	68421	TAS	slope of activity
MGI:2150404	Cosz1	MGI:2157139	Cosz1<DBA/2J>	MGI:2157139	Cosz1<DBA/2J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	66464	TAS	seizure resistance
MGI:2150404	Cosz1	MGI:2157139	Cosz1<DBA/2J>	MGI:2157139	Cosz1<DBA/2J>	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	66464	TAS	seizure resistance
MGI:2151923	Cpfd4	MGI:2157095	Cpfd4<NZB/BlNJ>	?	?	involves: C57BL/6By # NZB/BlNJ	central nervous system: other dysmorphology	71085	TAS	brain morphology
MGI:1890944	Derm1	MGI:2157106	Derm1<NC/Nga>	MGI:2157106	Derm1<NC/Nga>	involves: MSM/MS # NC/Nga	immune system: hypersensitivity	68698	TAS	dermatitis susceptibility
MGI:99950	Dob2	MGI:2157552	Dob2<SWR/J>	?	?	involves: AKR/J # SWR/J	growth/weight abnormality: postnatal	20700	TAS	obesity
MGI:2151000	Drb3	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	68421	TAS	dopamine receptor binding
MGI:1309473	Eae9	MGI:2157436	Eae9<B10.S/DvTe>	MGI:2157437	Eae9<SJL/J>	involves: B10.S/DvTe # SJL/J	immune system: hypersensitivity	49054	TAS	EAE susceptibility
MGI:1309473	Eae9	MGI:2157546	Eae9<ABH>	?	?	involves: ABH # NOD	immune system: hypersensitivity	29171	TAS	EAE susceptibility
MGI:95312	El1	?	?	?	?	involves: ABP/LeJ # EL 	neurological/behavioral: seizures/epilepsy	14263	TAS	epilepsy susceptibility
MGI:95312	El1	MGI:2157558	El1<EL>	?	?	involves: DBA/2J # EL	neurological/behavioral: seizures/epilepsy	11381	TAS	epilepsy susceptibility
MGI:95312	El1	MGI:2157558	El1<EL>	?	?	involves: ABP/LeJ # EL	neurological/behavioral: seizures/epilepsy	11381	TAS	epilepsy susceptibility
MGI:108256	El4	MGI:2157528	El4<EL/Suz>	?	?	involves: DDY/Jcl # EL/Suz	neurological/behavioral: seizures/epilepsy	30433	TAS	seizure frequency
MGI:108256	El4	MGI:2157528	El4<EL/Suz>	?	?	involves: ABP/LeJ # EL/Suz	neurological/behavioral: seizures/epilepsy	30433	TAS	seizure frequency
MGI:1858453	Etohc3	MGI:2157399	Etohc3<C57BL/6J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	52468	TAS	alcohol preference
MGI:2148662	Etohcta8	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	50271	TAS	alcohol preference
MGI:1933828	Feml2	MGI:2157112	Feml2<C57BL/6J>	?	?	involves: CAST/EiJ # C57BL/6J-Cish2<hg>/Cish2<hg>	skeletal: osteogenesis/developmental anomalies	68441	TAS	femur length
MGI:2137472	Hpic1	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	68417	TAS	catalepsy
MGI:2137472	Hpic1	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	61419	TAS	catalepsy
MGI:2148581	Hpic5	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	61419	TAS	catalepsy
MGI:2150693	Hts	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	67839	TAS	hypothermia
MGI:2150693	Hts	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	67839	TAS	quinpirole tolerance
MGI:2150693	Hts	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	67839	TAS	locomotor activity
MGI:1316685	Kwq3	?	?	?	?	involves: DU6 # DUKs	kidney/renal system: dysmorphology	49578	TAS	kidney weight
MGI:2148270	Lrnx3	?	?	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: learning/memory impairment	40226	TAS	contextual fear response
MGI:1889224	Lwq7	?	?	?	?	involves: DBA/2J # DU6i	liver/hepatic system: dysmorphology	66233	TAS	liver weight
MGI:2148818	Manh11	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	67526	TAS	madible morphology
MGI:2148819	Manh12	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	67526	TAS	madible morphology
MGI:1890670	Mob8	MGI:2157461	Mob8<CAST/Ei>	MGI:2157461	Mob8<CAST/Ei>	involves: CAST/Ei # C57BL/6J	growth/weight abnormality: postnatal	48038	TAS	adiposity
MGI:1890670	Mob8	MGI:2157461	Mob8<CAST/Ei>	MGI:2157460	Mob8<C57BL/6J>	involves: CAST/Ei # C57BL/6J	growth/weight abnormality: postnatal	48038	TAS	adiposity
MGI:2151859	Morph2	MGI:2157099	Morph2<DBA/2J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: sensory capabilities/reflexes/nociception abnormalities	70377	TAS	antinociception
MGI:2151860	Morph3	MGI:2157100	Morph3<C57BL/6J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: sensory capabilities/reflexes/nociception abnormalities	70377	TAS	antinociception
MGI:1349407	Obq5	MGI:2157358	Obq5<KK/HlLt>	MGI:2157358	Obq5<KK/HlLt>	involves: C57BL/6J # KK/HlLt	growth/weight abnormality: postnatal	57787	TAS	adiposity
MGI:1349407	Obq5	MGI:2157358	Obq5<KK/HlLt>	MGI:2157359	Obq5<C57BL/6J>	involves: C57BL/6J # KK/HlLt	growth/weight abnormality: postnatal	57787	TAS	adiposity
MGI:1196342	Oriq1	?	?	?	?	involves: A/J # C57BL/6J 	reproductive system: no defect detected	44129	TAS	ovulation rate
MGI:108510	Pas4	?	?	?	?	involves: A/JOlaHsd # BALB/cOlaHsd	tumors: increased incidence	21801	TAS	lung tumor susceptibility
MGI:2151213	Pgia5	MGI:2157141	Pgia5<BALB/cCrl>	?	?	involves: BALB/cCrl # DBA/2Crl	immune system: hypersensitivity	66460	TAS	inflammation susceptibility
MGI:1890506	Pid2	MGI:2157199	Pid2<CAST/Ei>	?	?	involves: CAST/Ei # SJL/J	central nervous system: other functional anomalies	65122	TAS	prion incubation time
MGI:2137605	Pnef	?	?	?	?	involves: C57BL/6J # KK-A<y>	metabolism: abnormal lipid homeostasis	54322	TAS	plasma non-esterified fatty acids
MGI:1345637	Psl1	MGI:2157475	Psl1<DBA/2>	?	?	involves: C57BL/6 # DBA/2	tumors: increased incidence	44548	TAS	skin tumor susceptibility
MGI:2150658	Pvcan2	?	?	?	?	involves: BALB/cByJ # C57BL/6ByJ	immune system: other functional anomaly	57639	TAS	candidiasis resistance
MGI:104989	Rapop2	MGI:2157468	Rapop2<BALB/cHeA>	?	?	involves: BALB/cHeA # STS/A	no obvious phenotype: no defect detected	30582	TAS	apoptosis susceptibility
MGI:104989	Rapop2	MGI:2157469	Rapop2<STS/A>	?	?	involves: BALB/cHeA # STS/A	no obvious phenotype: no defect detected	47265	TAS	apoptosis susceptibility
MGI:104989	Rapop2	MGI:2157484	Rapop2<C57BL/6J>	MGI:2157485	Rapop2<C3Hf/Kam>	involves: C3Hf/Kam # C57BL/6J 	no obvious phenotype: no defect detected	44257	TAS	apoptosis
MGI:1351478	Skts6	MGI:2157347	Skts6<NIH/Ola>	?	?	involves: M. spretus # NIH/Ola	tumors: increased incidence	59049	TAS	skin tumor susceptibility
MGI:1351478	Skts6	MGI:2157346	Skts6<M. spretus>	?	?	involves: M. spretus # NIH/Ola	tumors: increased incidence	59049	TAS	skin tumor resistance
MGI:2149694	Skull12	MGI:2157392	Skull12<LG/J>	MGI:2157392	Skull12<LG/J>	involves: LG/J # SM/J	skeletal: craniofacial defects	53484	TAS	skull morphology
MGI:2149694	Skull12	MGI:2157392	Skull12<LG/J>	MGI:2157393	Skull12<SM/J>	involves: LG/J # SM/J	skeletal: craniofacial defects	53484	TAS	skull morphology
MGI:2149695	Skull13	MGI:2157394	Skull13<LG/J>	MGI:2157394	Skull13<LG/J>	involves: LG/J # SM/J	skeletal: craniofacial defects	53484	TAS	skull morphology
MGI:2149695	Skull13	MGI:2157394	Skull13<LG/J>	MGI:2157395	Skull13<SM/J>	involves: LG/J # SM/J	skeletal: craniofacial defects	53484	TAS	skull morphology
MGI:1353456	Sles4	MGI:2157367	Sles4<C57BL/6>	MGI:2157368	Sles4<NZW>	involves: C57BL/6 # NZW	immune system: hypersensitivity	57246	TAS	SLE susceptibility
MGI:1353456	Sles4	MGI:2157368	Sles4<NZW>	MGI:2157368	Sles4<NZW>	involves: C57BL/6 # NZW	immune system: hypersensitivity	57246	TAS	SLE resistance
MGI:1335074	Sluc10	?	?	?	?	involves: B10.O20/Dem # O20/A	tumors: increased incidence	50525	TAS	lung tumor susceptibility
MGI:1335075	Sluc11	?	?	?	?	involves: B10.O20/Dem # O20/A	tumors: increased incidence	50525	TAS	lung tumor susceptibility
MGI:2136868	Smgd1	MGI:2157104	Smgd1<C57BL/6J>	?	?	involves: BALB/cJ # C57BL/6J	no obvious phenotype: no defect detected	69108	TAS	submucosal gland density
MGI:2136868	Smgd1	MGI:2157105	Smgd1<BALB/cJ>	?	?	involves: BALB/cJ # C57BL/6J	no obvious phenotype: no defect detected	69108	TAS	submucosal gland density
MGI:2148969	Taste11	?	?	?	?	involves: C3H/HeJ # C57BL/6J	neurological/behavioral: feeding/drinking preference anomalies	48606	TAS	bitterness sensitivity
MGI:2148970	Taste12	?	?	?	?	involves: C3H/HeJ # C57BL/6J	neurological/behavioral: feeding/drinking preference anomalies	48606	TAS	bitterness sensitivity
MGI:1345641	Tbs2	?	?	?	?	involves: A/SnYCit # I/StSnEgYCit	immune system: other functional anomaly	55857	TAS	body weight after infection
MGI:1330232	Tlf	MGI:2157567	Tlf<NOD/Smrf>	?	?	involves: NOD/Smrf # NON/Lt	hematology: no defect detected	49676	TAS	T lymphocyte level
MGI:1330232	Tlf2	MGI:2157569	Tlf2<NOD/Smrf>	?	?	involves: NOD/Smrf # NON/Lt	hematology: no defect detected	49676	TAS	T lymphocyte level
MGI:1343126	Tria5	MGI:2157373	Tria5<BALB/cHeA>	?	?	involves: BALB/cHeA # STS/A	immune system: lymphoid development/ T lymphocyte defects	56029	TAS	T lymphocyte proliferation
MGI:2137853	Aem3	MGI:2157943	Aem3<C57BL/6>	?	?	involves: C57BL/6 # NZB	immune system: hypersensitivity	59427	TAS	anti-erythrocyte autoantibody production
MGI:1858394	Alcp15	?	?	?	?	involves: A/J # C57BL/6J	neurological/behavioral: feeding/drinking preference anomalies	52467	TAS	alcohol preference
MGI:1858395	Alcp16	?	?	?	?	involves: A/J # C57BL/6J	neurological/behavioral: feeding/drinking preference anomalies	52467	TAS	alcohol preference
MGI:2152431	Ap4q	MGI:2157430	Ap4q<C57BL/6J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: feeding/drinking preference anomalies	49707	TAS	alcohol preference
MGI:2150642	Asm1	MGI:2157890	Asm1<MRL/MpJ>	?	?	MRL/MpJ-Tnfrsf6<lpr>/Tnfrsf6<lpr> x (MRL/MpJ-Tnfrsf6<lpr>/Tnfrsf6<lpr> X C3H/HeJ-Tnfrsf6<lpr>/Tnfrsf6<lpr>)F1	immune system: hypersensitivity	66459	TAS	sialadenitis susceptibility
MGI:2149830	Asthm1	?	?	?	?	(BP2 x BALB/c)F2	immune system: hypersensitivity	54405	TAS	airway hyperresponsiveness
MGI:108509	Bgeq8	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	32208	TAS	growth rate
MGI:108509	Bgeq8	?	?	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	60662	TAS	growth rate
MGI:1891178	Bsc1	MGI:2157859	Bsc1<C57BL/6J>	MGI:2157859	Bsc1<C57BL/6J>	involves: A/J # BXD-5/Ty	central nervous system: other dysmorphology	69683	TAS	striatal volume
MGI:1891178	Bsc1	MGI:2157859	Bsc1<C57BL/6J>	MGI:2157858	Bsc1<A/J>	involves: A/J # BXD-5/Ty	central nervous system: other dysmorphology	69683	TAS	striatal volume
MGI:1345626	Cia8	MGI:2157964	Cia8<DBA/1J>	MGI:2157964	Cia8<DBA/1J>	invovles: DBA/1 # B10.Q	immune system: hypersensitivity	57012	TAS	arthritis severity
MGI:1098223	Daq4	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	42413	TAS	mandible morphology
MGI:1098225	Daq5	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	42413	TAS	mandible morphology
MGI:1098227	Daq6	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	42413	TAS	mandible morphology
MGI:1891324	Eae15	MGI:2157872	Eae15<SJL/J>	?	?	involves: B10.S/DvTe # SJL/J	immune system: hypersensitivity	67840	TAS	brain lesion severity
MGI:1891326	Eae17	MGI:2157861	Eae17<SJL/J>	?	?	involves: B10.S/DvTe # SJL/J	immune system: hypersensitivity	69083	TAS	EAE severity
MGI:2137859	Ednrbm1	?	?	?	?	(Mayer EdnrbS/EdnrbS x C3HeB/FeJLe-a/a-Ednrb<s>)F1 x Mayer EdnrbS/EdnrbS	coat: color anomalies	60162	TAS	dorsal hypopigmentation
MGI:108249	El3	MGI:2157531	El3<EL/Suz>	MGI:2157531	El3<EL/Suz>	involves: ABP/LeJ # EL/Suz	neurological/behavioral: seizures/epilepsy	30433	TAS	seizure frequency
MGI:108249	El3	MGI:2157531	El3<EL/Suz>	MGI:2157532	El3<ABP/LeJ>	involves: ABP/LeJ # EL/Suz	neurological/behavioral: seizures/epilepsy	30433	TAS	seizure frequency
MGI:1346081	Estq4	?	?	?	?	involves: C3H/HeJ # C57BL/6J 	reproductive system: no defect detected	52898	TAS	uterine weight
MGI:1346081	Estq4	?	?	?	?	involves: C3H/HeJ # C57BL/6J 	immune system: other functional anomaly	52898	TAS	leukocytic infiltration
MGI:1346081	Estq4	MGI:2158118	Estq4<C57BL/6J>	?	?	involves: C3H/HeJ # C57BL/6J 	immune system: other functional anomaly	53494	TAS	leukocytic infiltration
MGI:1099805	Exq1	MGI:2157968	Exq1<C57BL/6J>	?	?	involves: A/J # C57BL/6J	neurological/behavioral: motor capabilities/coordination/movement anomalies	41249	TAS	exploratory behavior
MGI:1099805	Exq1	?	?	?	?	involves: A/J # C57BL/6J	neurological/behavioral: fear/anxiety	44650	TAS	fear response
MGI:1099805	Exq1	MGI:2157967	Exq1<A/J>	?	?	involves: A/J # C57BL/6J	neurological/behavioral: seizures/epilepsy	54925	TAS	seizure susceptibility
MGI:1858755	Geot	?	?	?	?	involves: C57BL/6By # NZB/BlNJ	neurological/behavioral: motor capabilities/coordination/movement anomalies	53794	TAS	geotaxia
MGI:1889233	Igf1q1	?	?	?	?	involves: DBA/2 # DU6i	metabolism: no defect detected	66233	TAS	insulin-like growth factor I concentration
MGI:1890485	Igfbp3q2	MGI:2157863	Igfbp3q2<DU6i>	?	?	involves: DBA/2 # DU6i	no obvious phenotype: no defect detected	68837	TAS	insulin like growth factor binding protein level
MGI:1932516	Insq4	MGI:2157898	Insq4<SM/J>	?	?	involves: A/J # SM/J	metabolism: abnormal glucose homeostasis	64138	TAS	insulin level
MGI:2148496	Insq9	MGI:2157922	Insq9<C57BL/6>	?	?	involves: 129/SvIR # C57BL/6	metabolism: abnormal glucose homeostasis	61489	TAS	insulin level
MGI:1203735	Lmb4	MGI:2158218	Lmb4<MRL>	?	?	involves: C57BL/6-Tnfrsf6<lpr> # MRL-Tnfrsf6<lpr>	immune system: hypersensitivity	45708	TAS	lymphadenopathy
MGI:1203735	Lmb4	MGI:2158218	Lmb4<MRL>	?	?	involves: C57BL/6-Tnfrsf6<lpr> # MRL-Tnfrsf6<lpr>	immune system: hypersensitivity	45708	TAS	splenomegaly
MGI:2148583	Lrnx8	MGI:2158219	Lrnx8<C57BL/6J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: learning/memory impairment	43837	TAS	contextual fear response
MGI:1316741	Lwq3	?	?	?	?	involves: DU6 # DUKs	liver/hepatic system: dysmorphology	49578	TAS	liver weight
MGI:2148820	Manh13	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	67526	TAS	mandible morphology
MGI:2148821	Manh14	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	67526	TAS	mandible morphology
MGI:2148845	Many1	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	67526	TAS	mandible morphology
MGI:2148837	Manz6	?	?	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	67526	TAS	mandible size
MGI:99508	Mop2	MGI:2158228	Mop2<C57BL/6J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	17972	TAS	morphine consumption
MGI:2151861	Morph4	MGI:2157838	Morph4<DBA/2J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	70377	TAS	antinociception
MGI:2151861	Morph4	MGI:2157838	Morph4<DBA/2J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: no defect detected	70377	TAS	antinociception
MGI:2137610	Oriq5	?	?	?	?	involves: A/J # C57BL/6J	reproductive system: no defect detected	58026	TAS	ovulation rate
MGI:2151214	Pgia6	MGI:2157144	Pgia6<BALB/cCrl>	?	?	involves: BALB/cCrl # DBA/2Crl	immune system: hypersensitivity	66460	TAS	autoantibody production
MGI:1347110	Scc9	MGI:2157956	Scc9<STS/A>	?	?	involves: BALB/cHeA # CcS-5	tumors: increased incidence	57235	TAS	colon tumor susceptibility
MGI:2149829	Scpro3	?	?	?	?	involves: C3H/HeJ # C57BL/6	immune system: no defect detected	54115	TAS	stem cell proliferation
MGI:2149053	Skl4	MGI:2157907	Skl4<LG/J>	?	?	involves: LG/J # SM/J	growth/weight abnormality: postnatal	62610	TAS	tail length
MGI:2149696	Skull14	MGI:2158051	Skull14<LG/J>	?	?	involves: LG/J # SM/J	skeletal: craniofacial defects	53484	TAS	skull morphology
MGI:2149721	Sle12	MGI:2158122	Sle12<C57BL/6J>	MGI:2158123	Sle12<NZM2410/Aeg>	involves: C57BL/6J # NZM2410/Aeg 	immune system: hypersensitivity	52863	TAS	glomerulonephritis resistance
MGI:1889231	Swq5	?	?	?	?	involves: DBA/2 # DU6i	immune system: other dysmorphology	66233	TAS	spleen weight
MGI:2148671	Szs9	MGI:2157843	Szs9<DBA/2J>	?	?	involves: C57BL/6J # DBA/2J	neurological/behavioral: seizures/epilepsy	70295	TAS	seizure susceptibility
MGI:2150915	Uvbi1	?	?	?	?	involves: BALB/cAnNCr # C57BL/6NCr	immune system: other functional anomaly	68418	TAS	immunosuppression resistance